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POPULAR SCIENCE SUMMARY 
Spinal cord controls the communication between the brain and the body and coordinates the 
motor movements and sensory functions. When an injury occurs to the spinal cord, the signal 
bridge between the brain and the body is impaired, resulting in partly or fully functional loss 
of the body below the lesion level. The main reason is that after spinal cord injury (SCI), the 
neurons and other helper cells in the spinal cord die, and this cell loss is a continuous process 
even long after the injury has occurred. There is no cure so far for SCI, but several new 
treatments based on stem cell therapy have been studied in this thesis.  
Stem cells are cells that can generate more identical cells to themselves, and can also become 
other cell types as “self-reproductive transformers”. After SCI, spinal cord stem cells can 
activate the self-production system to produce more stem cells, move to the lesion area, and 
also become other helper cells to compensate for the cell loss. However, we found that the 
capacity of spinal cord stem cells decreases dramatically during aging, and the ways they 
contribute to self-recovery are different at young and mature age, suggesting that the current 
standard treatments for SCI need to take age into more consideration. Moreover, the 
regeneration capacity of stem cells and other helper cells at adult age has been largely 
determined during embryonic development, but many current studies only focus on the adult 
stage and overlook the link between development and regeneration. Here we found a gene, 
called FoxJ1, which regulates the embryonic development of the spinal cord, and is essential 
to maintain the stem cell potential in adulthood and after SCI. Targeting this gene could be a 
novel approach to recruit more spinal cord stem cells and provide better SCI treatments. 
Furthermore, a severe SCI patient received the transplantation of cells extracted from part of 
his own olfactory system in the brain, which made him the first severe SCI patient walk again 
with limited side effects. The surgery was successful, but the reasons were unknown, leading 
to a difficulty in achieving the same effect on other SCI patients. We studied the mechanisms 
behind and found that this type of cells originally from the olfactory system cannot generate 
other cells after being transplanted into the injured spinal cord, but they can stimulate the spinal 
cord stem cells to generate more stem cells and give rise to a more substantial number of 
beneficial helper cells. Moreover, it is widely believed that there are no newborn neurons in 
the adult spinal cord, resulting in the permanent loss of neurons in case of SCI. However, our 
study found that after this cell therapy, there are newborn neurons in the spinal cord after SCI. 
We suggest that a further study on the molecules produced by this cell therapy will be of high 
importance for developing new cell therapies for SCI. 
Altogether, this thesis sheds some light on the understandings about how the spinal cord is 
developed, and how this developmental process influences the stem cell potential at adulthood 
and after SCI. This thesis provides some inspirations to target specific cell types and genes for 
new therapeutic possibilities for SCI. 
作为中枢神经系统的一部分，脊髓控制着运动和感觉，是大脑和躯体的沟通的桥梁。
如果脊髓发生损伤，大脑和身体之间的信号传输就会受到阻碍，导致在损伤位置以下
甚至全部躯体功能的丧失。这主要是由于损伤发生后，脊髓中的神经元和其他的辅助
细胞大量死亡，而且细胞死亡过程会一直持续到损伤发生后的很长一段时间。目前脊
髓损伤尚无法治愈，但本文研究了几种基于干细胞的新疗法。 
干细胞是一种能自我更新，并可以分化成其他细胞类型的“变形金刚”。脊髓损伤后，
脊髓干细胞能够激活自我更新的能力，产生更多的干细胞，并且能迁移到病变区域，
分化成其他类型的细胞以补偿损伤造成的细胞死亡。然而，我们发现在机体衰老的过
程中，脊髓干细胞的这种自我更新和变化能力急剧下降。因此在年轻和年老时期，脊
髓的自我恢复的方式大不相同，提示当前脊髓损伤的治疗方案需要更进一步考虑年龄
的影响。此外，成年期干细胞和其他辅助细胞的再生能力在胚胎发育过程中已基本被
确定，但目前许多研究却仅关注成体期，忽略了胚胎发育和组织再生的关联。本论文
中，我们发现了一种叫 FoxJ1 的基因，它能调节脊髓的胚胎发育，并且在成年期，当
脊髓发生损伤后，对维持干细胞的潜能至关重要。靶向这个基因可能会带来新的基因
疗法，刺激并获得更多的脊髓干细胞，从而提供更好的脊髓损伤治疗的可能性。 
此外，一名严重脊髓损伤患者接受了细胞移植手术，细胞来源于他自己的嗅觉系统。
这个手术使他成为第一个能重新获得行走能力的严重脊髓损伤患者，而且术后副作用
很小。但由于机理不明，这个手术的成功并不能使其他脊髓损伤的患者获得同样的疗
效。我们对这种疗法进行了研究，发现虽然这种类型的细胞在移植到受损的脊髓后并
不能产生其他细胞，但是它们可以刺激脊髓干细胞产生更多的干细胞并分化出大量有
益的辅助细胞。更有趣的是，人们普遍认为，成年脊髓中不能再出生出新的神经元，
因此脊髓损伤导致的神经元丧失是永久的。然而，我们的研究发现，在经过这种细胞
疗法之后，损伤的脊髓出现了新生的神经元。因此，我们建议进一步研究究竟是这种
细胞产生的何种分子起的作用，这对于促进脊髓损伤的新细胞疗法的发现非常重要。 
总之，本文对研究脊髓发育以及脊髓发育过程如何影响成年和脊髓损伤后的干细胞潜
能提供了新的思路，并为脊髓损伤的细胞和基因疗法提供了一些新启示，从而为脊髓
损伤的治疗提供了新的可能性。 
 
 
  
ABSTRACT 
Spinal cord injury (SCI) is an incurable condition, which is mainly due to the highly limited 
regenerative potential of the adult spinal cord. The discovery of ependymal cells as the source 
of spinal cord stem cells raises hopes for the development of new therapies, while cell 
transplantations for SCI also provide promising means for potential treatments. However, 
curing SCI has been proven difficult as the potential of these progenitors and ependymal stem 
cells is still understudied. Moreover, the development of the spinal cord is a key factor 
influencing the regenerative potential of neural stem/progenitor stem cells, but the link between 
the development of spinal cord progenitors and adult spinal cord regeneration has been largely 
overlooked. By using different transgenic mouse lines and biomedical techniques, we studied 
the neural progenitors and stem cells during spinal cord development, after SCI and after cell 
transplantation in this thesis.  
FoxJ1 is traditionally regarded as a transcription factor involved in ciliogenesis and a specific 
marker for ependymal cells. In Paper I, however, we discovered that FoxJ1 is transiently 
expressed in neuronal and glial progenitors, which will further give rise to subsets of 
interneurons, two subsets of astrocytes and all ependymal cells. FoxJ1 is required for the 
maintenance of stemness of the progenitors during development and the stem cell potential 
during adulthood. After SCI, FoxJ1 is required for the normal stem cell potential, proliferation 
and migration of ependymal cells to promote regeneration.  
After the early developmental stage, in Paper II, we observed that the stem cell potential is 
fully confined to ependymal cells from P10 in mice, and the potential of self-renewal and 
oligodendrocytic differentiation decreases over time. Juvenile ependymal cells have higher 
stem cell potential after SCI than adult ones, but their contribution to the glial scar formation 
in vivo is lesion size- and age-dependent. We found that the resident astrocytes and stromal 
derived pericytes show higher regenerative potential at the juvenile stage, and ependymal cells 
serve as a backup regeneration candidate after SCI. 
Clinically in the adult spinal cord, the transplantation of bulbar olfactory ensheathing cell 
(bOEC) has shown significant functional recovery in SCI patients, but the mechanisms are not 
elucidated. In Paper III, we found that after SCI, bOEC transplantation increases the 
proliferation and self-renewal potential of ependymal cells. The transplantation of bOECs 
promotes higher astrocytic differentiation of ependymal cells but reduces the axonal growth 
inhibitors after SCI. The microenvironment of the injured spinal cord is enriched after bOEC 
transplantation in terms of less axonal growth inhibitor, a higher level of neurotrophic factors 
and better neuronal survival. Unexpectedly, we found newborn neurons after SCI with bOEC 
transplantation, challenging the current central stream theory that there is no neurogenesis after 
SCI. 
Altogether, this thesis provides new insights into the potential of ependymal cells and 
progenitors during development, regeneration after SCI and after transplantation for SCI 
treatment, and hopefully can contribute to new therapeutic approaches. 
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1 INTRODUCTION  
The central nervous system (CNS) consists of the brain and the spinal cord. The spinal cord 
serves as a key bridge for the communication between the brain and the body. Notably, it 
serves both as the final output command for the elaboration of movements, such as walking 
or breathing, as well as the first input connection for most sensory modalities. When injury 
occurs to the spinal cord, the lesion partly or completely disrupts the signal transduction 
along the CNS, leading to permanent functional impairment in motor and sensory system 
below the lesion, and typically resulting in neuropathic pain, paralysis, and the dysfunction 
or disorder of the digestion system and reproductive system (Westgren and Levi, 1998). 
Spinal cord injury (SCI) is currently a chronic incurable disease without clear epidemiology 
statistics. However, it is estimated that 9.2 to 246 cases per million of the population a year 
varying from different regions (Li et al., 2016; Siddiqui et al., 2015). The majority of SCI 
patients are at the age between 10-40 years old at the time of injury (Siddiqui et al., 2015) 
and the life quality and expectancy of these young people are extensively and deeply 
influenced (Center, 2015; Li et al., 2016). Recently, new studies based on stem cell 
therapies have opened up new promising avenues. Indeed, by manipulating endogenous 
stem and progenitor cells or by cell transplantation after SCI, these cells can contribute to 
spinal cord regeneration, including tissue repair and functional recovery (Assinck et al., 
2017; Gregoire et al., 2015).   
Stem cells are cell types with unlimited self-renewal potential and multipotent capacity. 
Self-renewal is the process that stem cells divide to generate more identical themselves, 
maintaining the stem cell pool throughout life, while differentiation is the process by which 
more specialized cells are formed from stem cells. Self-renewal and differentiation occur 
spontaneously during organ development from embryonic stages to adulthood and can be 
specifically mobilized under different pathological conditions.  In general, the most potent 
stem cells are found in early embryonic stages, and the stem cell properties decrease during 
development and aging (Silva-Vargas et al., 2013). Other progenitor cells, on the other 
hand, do not share all the characteristics of stem cells, but can also contribute to 
regeneration after SCI (Sabelstrom et al., 2014; Stenudd et al., 2015). 
After embryonic development, except for tissues with fast turnover such as skin or intestine 
(Li and Clevers, 2010), adult stem cells maintain their population by self-renewal with 
relatively low division rate and rarely generate fast dividing progenitor cells. In the CNS, 
adult neural stem cells are mainly restricted in the ventricular-subventricular zone of the 
lateral ventricles, the subgranular zone of the hippocampus in the brain, and in the central 
canal of the spinal cord, with limited self-renewal and differentiation potential (Seaberg 
and van der Kooy, 2003). Although stem and progenitor cells give hope for the recovery 
after SCI or other neurodegenerative diseases, the regeneration capacity of the adult spinal 
cord is insufficient (Gregoire et al., 2015). Moreover, the capacity of adult stem and 
progenitor cells after injury is mostly influenced or determined during the developmental 
process, but the link and the mechanisms are still largely unknown. Therefore, to further 
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develop new SCI therapies, it is crucial to understand the cellular and molecular properties 
of stem and progenitor cells during both embryonic development and adult regeneration 
(Becker and Diez Del Corral, 2015; Gage and Temple, 2013).   
1.1 THE DEVELOPMENT OF SPINAL CORD  
1.1.1 Neurogenesis during spinal cord development  
The spinal cord comprises the caudal region of the CNS and serves as a bridge, through 
which the motor and sensory information travel between the brain and the periphery. At 
the early stage of spinal cord development before embryonic day (E) 9 in mice, neural 
epithelial cells (NECs) are under fast proliferation and by migrating away, they expand the 
dorso-ventral and rostro-caudal dimensions of the spinal cord. Later on, NECs start to lose 
their epithelial properties and acquire features associated with glial cells and termed radial 
glial cells (RGCs) (Kriegstein and Alvarez-Buylla, 2009). RGCs are found to be neural 
precursors throughout the whole CNS, and give rise to neurons and glial cells during neural 
development, following a spatial-temporal manner (generating neurons first, then glial cells 
later). This cell fate specification process is primarily determined at an early developmental 
stage, neural patterning, the biological process by which cells in the developing CNS 
acquire distinct identities according to their specific spatial positions. At the molecular 
level, the key player of neural patterning is morphogens, soluble secreted signaling 
molecules from roof-plate or floor-plate that follow gradient distribution. These 
morphogens include fibroblast growth factors (FGF), retinoic acid (RA), Sonic hedgehog 
(Shh), bone morphogenetic proteins (BMP) and Wnts, and govern the arrangements of 
subtypes of neural precursors and direct their cell fate specification (Gurdon and Bourillot, 
2001; Kiecker and Lumsden, 2012).  
In the dorsal spinal cord, the regulation of neurogenesis is still not well understood, but 
many experiments have suggested that two of the key players, BMP and Wnts, determine 
the dorsal patterning. BMP and Wnt proteins are secreted by the roof plate and therefore 
are expressed in a graded manner from the dorsal (high) to the ventral (low) developing 
spinal cord. Progenitors respond to a specific concentration of these proteins by the 
expression or repression of a specific combination of transcription factors (TFs). These 
TFs, in turn, direct the determination of progenitor cells. Therefore, the dorso-ventral 
gradient of morphogens directs progenitors to differentiate into six distinct position-
dependent domains of postmitotic dorsal neurons (dI1-6) between E10 and 12.5 in mice 
(Figure 1) and (Alaynick et al., 2011; Liem et al., 1997). Genetic studies showed that 
disturbed expression of BMP- or Wnt- associated factors, such as Lmx1a, Gdf7, 
Wnt1/Wnt3a perturb neuronal cell fate determination in different domains in the dorsal 
spinal cord during development (Chizhikov and Millen, 2004; Lee et al., 2000; Liem et al., 
1997; Millonig et al., 2000; Muroyama et al., 2002). However, the study on dorsal spinal 
cord neurogenesis still faces many challenges. Genetic inactivation of individual TFs often 
results in normal spinal cord development (Kiecker and Lumsden, 2012) , which is mainly 
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because the roof plate secretes several types of Wnts and a large number of BMPs, therefore 
single inactivation can be compensated by the other TFs.   
Neurogenesis of ventral spinal cord is relatively better studied than the dorsal half as more 
TFs have been investigated by the use of transgenic animals. Probably it is because that 
this system serves primarily as motor control and motor functions and is easier to study for 
phenotypes. The patterning is essentially regulated by Shh, a morphogen released from the 
notochord and by the floor plate during ventral spinal cord development. During the 
patterning of ventral spinal cord, Shh is expressed in a gradient manner, from ventral (high) 
to dorsal (low) found to be declining when distributed from ventral to dorsal (Chamberlain 
et al., 2008). As a consequence, segmental expression of the homeodomain and basic helix–
loop–helix (bHLH) TFs subsequently engage in cross-repressive interactions to refine 
domain boundaries. For example, the expression of the homeobox protein IRX3 is 
repressed by Olig2, and NKX2.2–PAX6 leads to reciprocal repression (Rowitch and 
Kriegstein, 2010). Moreover, the concentration and exposure time of Shh regulates the 
expression of distinct TFs during spinal cord development, such as Olig 2 and Nkx2.2, 
which further direct the specification of subtypes of neurons in the developing ventral 
spinal cord following a temporal-spatial manner (Dessaud et al., 2008; Dessaud et al., 2007; 
Lupo et al., 2006). The Shh gradient activates or represses a number of TFs, giving rise to 
spatially segregated progenitor domains: FP (Foxa2), p3 (Nkx 2.2), pMN (Olig2), p2 
(Nkx6.1 and Irx3), p1 (Nkx6.2) and p0 (Dbx1), where the listed genes encode TFs that 
specify each domain (Alaynick et al., 2011; Guerout et al., 2014). Progenitors in each 
domain further differentiate into distinct neuronal subtypes, which are traditionally 
categorized as motor neurons derived from the progenitors in the pMN domain, and V0, 
V1, V2 and V3 interneurons derived from progenitors in p0–p3 domains respectively 
(Figure 1). Importantly, each of these genetically or developmentally defined progenitor 
types give rise to functionally-distinct neuronal types. Indeed, neurons originating from a 
similar progenitor domain often share similar position, morphology, projection profile, 
electrophysiological properties. In other words, the progenitor cell origin of a neuron has 
become a good predictor of its functional properties and functional role in the mature circuit 
(Alaynick et al., 2011; Kiehn, 2016). More recently, taking advantages of transgenic animal 
models, studies in developmental biology have shown that each population of interneurons 
(V0, V1 V2, and V3) can be even further divided into subgroups based on distinct gene 
expression profiles (Bikoff et al., 2016; Lu et al., 2015). Even though there are overlaps of 
makers for different subtypes of interneurons, subpopulations of interneurons can now be 
defined by combinatorial expression of TFs. For instance, V0 interneurons express Pax2, 
Pax6, and Evx1; V1 interneurons express Pax2, Evx1, Nurr1; and V2 interneurons express 
Pax2 and Chx10 (Francius et al., 2013).  
Nevertheless, the TFs involved in neurogenesis and neurodevelopment is under active 
studies and characterizations. Forkhead Box protein J1 (FoxJ1), for instance, is a 
transcription factor mostly involved in ciliogenesis and previously considered as a specific 
marker for adult ependymal cells in the spinal cord. However, we unexpectedly found that 
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FoxJ1 is also involved in spinal cord neurogenesis and development. We used FoxJ1 
lineage tracing animal models and some of the combinations of TFs mentioned above to 
identify further the subtypes of neurons derived from FoxJ1 progenitor cells, and we found 
that FoxJ1 is transiently expressed by the progenitors of V1 and V2 interneurons during 
embryonic development, which will be further discussed in detail later (Figure1; Paper I/Li 
et al., 2018).      
1.1.2 Gliogenesis during spinal cord development  
Gliogenesis in the developing CNS takes place after neurogenesis at the later stage of 
embryonic development after neurogenesis. Recent genetic studies have shown that similar 
to neurogenesis, most glial cells, including astrocytes, oligodendrocytes, and ependymal 
cells also differentiate in a spatial-temporal manner (Hochstim et al., 2008; Tsai et al., 2012; 
Xie et al., 2012).  
Astrocytes are the largest population of glial cells in the CNS, which guide the migration 
of developing axons and play an essential role in releasing signals for synapse formation 
and function (Barres, 2008; Powell and Geller, 1999; Sofroniew and Vinters, 2010). In the 
developing spinal cord, the dorso-ventral axis is segmented into distinct domains under the 
influence of morphogens during neural patterning as described above. After early 
embryonic neurogenesis, neural tube progenitor domains switch to a glial fate at around 
E12.5 in mice. In the ventral spinal cord, progenitors from p1, p2, and p3 domains, which 
give rise to neurons during neurogenesis at E10-E14 in mice, have been shown to be the 
precursors of three molecularly heterogeneous subpopulations of astrocytes, VA1-3 
astrocytes during gliogenesis. These subtypes of astrocytes are specified by the gradients 
of BMP and Shh, as well as the combinatorial expression of transcription factors Pax6 and 
Nkx6.1 (Hochstim et al., 2008). After differentiation, VA1-3 astrocytes can be further 
characterized by their expression of the axon and the neuronal migration factors Slit1 and 
Reelin, and their migration to the lateral white matter of the spinal cord, mirroring the 
localization of the progenitors in the p1–3 domains (Hochstim et al., 2008). Furthermore, 
a segmental model of astrocyte specification and migration was proposed by a recent study. 
By using a number of transgenic mouse lines, progenitors from different domains 
expressing distinct transcription factors such as Pax3, Msx3, Dbx1, Olig2, Ngn3, and Nkx 
2.2 along the dorso-ventral axis were fate mapped (Tsai et al., 2012). Astrocytes derived 
from each domain migrate radially, according to the dorso-ventral position of their 
neuroepithelial precursor. Postnatally, different subtypes of astrocytes have insufficient 
migratory potential in both intact and injured spinal cord. Therefore, astrocytes are 
regionally allocated into the spinal cord according to a segmental template with 
heterogeneous subtypes (Tsai et al., 2012). Besides, our study recently showed that FoxJ1 
is transiently expressed by progenitors of specific subsets of astrocytes during embryonic 
spinal cord development. One subpopulation of FoxJ1 progenitor-derived astrocytes 
migrates to the lateral white matter, similarly to Reelin-Slit V1-V3 astrocytes. The other 
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FoxJ1 progenitor-derived astrocytes migrate to the dorsal funiculus, explicitly labeling a 
subset of astrocytes with unreported origin from Pax3+ astrocytes (Paper I/Li et al., 2018).   
Oligodendrocytes are myelin-forming cells in the CNS, differentiated from 
oligodendrocyte precursor cells (OPCs). Studying the development of oligodendrocytes 
and OPCs helps to understand the regulations of myelin production and the regeneration 
capacity in CNS diseases and injuries. Indeed, during the progress of most of SCI, the 
necrosis and apoptosis of oligodendrocytes, the failure of sufficient production of 
oligodendrocytes from OPCs, and the continuous myelin degeneration are crucial factors 
that result in pathology and functional loss. During development, RGCs in the ventricular 
zone undergo asymmetric division, giving rise to one daughter cell retaining contact with 
the ventricular and pial surface, and another daughter cell (OPC) migrating to the gray or 
white matter (Pringle and Richardson, 1993). Even though the origin of OPCs in the spinal 
cord is not very well known due to the limitation of genetic animal models, OPCs are found 
to originate from several domains after neural patterning. In the ventral spinal cord, under 
the effects of BMP and Shh, the transcription factor Olig2 is specifically expressed in the 
pMN domain and is phosphorylated before and during neurogenesis, which results in the 
differentiation of progenitors to motor neurons. However, after E12 in mice, Olig2 
undergoes dephosphorylation and heterodimerize with neurogenin 2, contributing to the 
cell fate change from neural to oligodendrocyte fate (Li et al., 2011). Furthermore, the 
Notch ligand Jagged2 (JAG2), a Shh-regulated factor transiently expressed in motor neuron 
progenitors (pMNs) leads to motor neuron to OPC cell fate switch (Rabadan et al., 2012).  
Interestingly, the disruption of  Shh signaling does not deplete all OPC production in the 
dorsal spinal cord, suggesting that FGF or other factors may compensate for the loss of Shh 
at least partly (Cai et al., 2005; Vallstedt et al., 2005). After the production of OPCs in the 
ventral domain pMN, the second wave of OPC production starts in the dorsal spinal cord 
at around E15. This process is determined by transcription factors including Pax7 and 
Dbx1, potentially from dI3-dI5 domains (Fogarty et al., 2005; Vallstedt et al., 2005). OPCs 
derived from dorsal and ventral spinal cord are respectively around 20% and 80% during 
development (Tripathi et al., 2011). From E18 in mice, OPCs start generating mature 
myelinating oligodendrocytes, reaching a peak at 2-4 weeks after birth and continue until 
eight months postnatally (Figure 1) and (Rivers et al., 2008).  
Ependymal cells are multi-ciliated glial cells lining the ventricular system, forming a 
continuous cellular barrier between the cerebral-spinal fluid (CSF) and the adjacent 
parenchyma. The cilia beating of ependymal cells is responsible for CSF flow, brain 
homeostasis, and normal functions of adult neural stem cells in the spinal cord (Guerout et 
al., 2014). Ependymal cells have been categorized into three subtypes by their 
morphological and molecular features (tanycytes, cuboidal and radial ependymal cells) but 
the developmental process and the functional differences of ependymal cells are largely 
unknown (Meletis et al., 2008; Robins et al., 2013; Spassky et al., 2005). Factors such as 
homeobox transcription factor Six3, Numb/Numlike proteins, and SNX27 were suggested 
to be crucial for ependymal layer formation in the brain (Kuo et al., 2006; Lavado and 
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Oliver, 2011; Wang et al., 2016b).  During spinal cord development, Shh is essential for 
ependymal cell differentiation, and deletion of Shh leads to the absence of ependymal layer 
(Yu et al., 2013). Moreover, FoxJ1 is found to be expressed explicitly in adult spinal cord 
ependymal cells, and have been used as a spinal cord neural stem cell marker (Barnabe-
Heider et al., 2010; Meletis et al., 2008).  In the developing spinal cord, the first FoxJ1+ 
ependymal cells appear earliest at E15.5 in mice by expressing FoxJ1 around the 
ventricular/ central canal, and quickly expand their population and almost entirely occupy 
the central canal by birth. Around postnatal day 10 (P10), FoxJ1 is restricted to the 
ependymal cells which have fully formed the ependymal layer around the central canal, 
displaying the unique stem cell source of the spinal cord (Li et al., 2016) /(Paper II).  
 
Figure 1. The developing spinal cord is regulated by morphogens and various transcription factors. 
During the development of the spinal cord, morphogens are secreted from the floor plate and roof plate, and 
distributed in a gradient manner, regulating the expression of a number of transcription factors (middle panel). 
During neurogenesis, specific transcription factors define domains of progenitors along the dorsal-ventral axis 
and further give rise to distinct neuronal subtypes (left panel), while other transcription factors in specific 
domains regulate the development of astrocytes and oligodendrocyte precursor cells during gliogenesis (right 
panel).  The transcription factor FoxJ1 (in bold font with green background), is mainly expressed in the p1-
p2 domains and the floor plate during early development and found to be continuously occupying the central 
canal from E15 onwards, which further regulates the progenitors to give rise to V1 and V2 interneurons, a 
subset of astrocytes and ependymal cells. 
1.1.3 The development of spinal cord stem cells  
Embryonic stem cells from neuroepithelium of ectodermal origin are the most potent stem 
cells during early neurodevelopment. However, the stem cell potential starts to decline 
when neuroepithelial cells begin to specialize into different RGCs around E9-10 in mice. 
In the brain, adult neural stem/progenitor cells share a common progenitor pool with 
different types of embryonic progenitors that give rise to cells of different regions of the 
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brain, including the cortex, striatum, and septum during development. However, this 
lineage relationship among all the progenitors is lost before E15.5 in mice. Indeed, adult 
neural stem cells were allocated and specified early in embryonic development, and the 
lineages between adult and embryonic stem cells diverge during mid-embryonic 
development (Fuentealba et al., 2015). Moreover, the majority of adult cells with 
stem/progenitor cell potential in mice are derived between E13.5 and E15.5 in the brain 
and between E15.5 and P0 in the spinal cord, and remain mostly quiescent in the adulthood 
(Bond et al., 2015; Fuentealba et al., 2015; Li et al., 2016). Even though these stem cells 
remain mostly quiescent during postnatal development and adulthood, they can be 
reactivated under certain conditions, such as injury or stroke (Bond et al., 2015; Fuentealba 
et al., 2015). In the spinal cord, it is still not clear how the adult neural stem cells obtain 
their potential during development, but during neurogenesis and gliogenesis, RGCs and 
other intermediate precursor cells maintain their stem cell potential to both generate their 
population and give rise to specific differentiated progeny (Temple, 2001). However, the 
frequency of stem cells is diluted by the production of restricted progenitors and 
differentiated cells, dropping to 10% at E12 and only 1% at P1 in the spinal cord (Kalyani 
et al., 1997; Kalyani et al., 1998). The spinal cord stem cell potential is gradually restricted 
from progenitors to ependymal cells since they begin to appear as differentiated cells at 
E15. After the first wave of ependymal cells, they quickly take over the full stem cell 
population within three weeks in mice till around P10 (Li et al., 2016/ Paper II). Using 
genetic labeling of ependymal cells by FoxJ1-CreER transgenic mice and cell culture 
studies have shown that the first ependymal cells have stem cell potential as early as E15 
while almost 100% stem cells are ependymal cell-derived at P10. This data suggest that 
embryonic spinal cord stem and progenitor cells from other sources rapidly lose their stem 
cell potential during development, and the only source of stem cells after birth is confined 
to ependymal cells around the central canal (Li et al., 2016/ Paper II).  
1.2 SPINAL CORD STEM/PROGENITOR CELLS AT JUVENILE STAGE AND 
ADULTHOOD  
After embryonic and early postnatal development of the spinal cord, neurogenesis and 
gliogenesis have been mostly completed. Neurons, astrocytes, oligodendrocytes have been 
distributed in gray matter or white matter while ependymal cells are restricted around the 
central canal. Spinal cord astrocytes share similarities with brain astrocytes, including 
neurotrophic factor secretion, contribution to metabolism and maintenance of homeostasis 
(Sofroniew and Vinters, 2010). Besides, spinal cord astrocytes are involved in blood spinal 
cord barrier formation and prevent the influx of antigens or molecule at a certain size to the 
parenchyma of the spinal cord (Bartanusz et al., 2011). However, unlike subtypes of 
astrocytes (or GFAP-expressing glial cells) that can give rise to neurons during embryonic 
development and are involved in adult neurogenesis in the brain, spinal cord astrocytes do 
not have stem cell potential in both healthy and injured spinal cord (Barnabe-Heider et al., 
2010). In the intact adult spinal cord, in vivo astrocytes are under low proliferation rate and 
do not give rise to non-astrocytic progeny. Moreover, fate-mapping experiments showed 
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that astrocytes form a small number of primary neurospheres but are not capable of being 
passaged, suggesting that spinal cord astrocytes do not have real stem cell potential 
(Barnabe-Heider et al., 2010; Buffo et al., 2008). It is still largely unknown how aging 
affects astrocytes in the spinal cord over time. Previous data about the effects of aging in 
the brain showed that astrocytes in the neurogenic zone, the subventricular zone (SVZ), are 
less dividing over time, as well as undergo morphology changes and express a lower level 
of GFAP, DCX and S100 (Capilla-Gonzalez et al., 2014). 
Oligodendrocytes produce myelin, an insulating sheath required for the saltatory 
conduction of electrical impulses along axons in the CNS. They are derived from 
oligodendrocyte progenitor cells (OPCs) under physiological condition (Ffrench-Constant 
and Raff, 1986; Raff et al., 1983a; Raff et al., 1983b). OPCs are distributed in both gray 
and white matter throughout the CNS. During the differentiation of OPCs into 
oligodendrocytes, multiple processes are extended, and axons are ensheathed, and then the 
oligodendrocytes proceed to generate the concentric layers of the modified cell membrane 
that compose myelin (Sherman and Brophy, 2005). Even though OPCs are proliferating 
lifelong to generate new oligodendrocytes in mice, it was shown that NG2+ and Olig2+ 
OPCs are not multipotent and restricted to the oligodendrocyte lineage (Barnabe-Heider et 
al., 2010; Kang et al., 2010). During aging, the myelination of CNS becomes less efficient, 
due to both the impairment of OPC recruitment and the differentiation of OPCs to 
oligodendrocytes, which was found to be associated with the changes of environmental 
signals and epigenetic changes within OPCs (Hinks and Franklin, 2000; Shen et al., 2008; 
Sim et al., 2002; Tang et al., 2000). 
Ependymal cells are lining the central canal in adulthood with a low proliferation rate in 
vivo. During postnatal development, ependymal cells are contributing to the elongation of 
the central canal and the flow of cerebrospinal fluid (Alfaro-Cervello et al., 2012; Sabourin 
et al., 2009). Similarly, ependymal cells at adulthood undergo symmetric division, but all 
their progeny remain in the ependyma, suggesting that their primary role in adults is 
ependymal cell maintenance (Barnabe-Heider et al., 2010). Despite the low proliferation 
rate in the intact spinal cord, it was shown that ependymal cells are capable of generating 
neurospheres, with the self-renewal potential over many passages (Barnabe-Heider et al., 
2010). Moreover, even though ependymal cells do not give rise to other cell types in the 
intact spinal cord, the neurospheres derived from ependymal cells in vitro display 
multipotent phenotype by differentiating into astrocytes, oligodendrocytes, and neurons 
(Barnabe-Heider et al., 2010; Li et al., 2018; Li et al., 2016; Meletis et al., 2008). In the 
aging adult brain, ependymal cells were found to undergo morphology changes, including 
a higher number of intermediate filaments in the cytoplasm, presenting larger lipid droplets, 
and concentrated cilia in limited areas (Capilla-Gonzalez et al., 2014). In the spinal cord, 
the stem cell potential of ependymal cells declines quickly over time from juvenile to 
adulthood in vitro, by displaying less self-renewal capacity and a dramatic decrease of 
oligodendrocytic differentiation potential (Barnabe-Heider et al., 2010; Li et al., 2018; Li 
et al., 2016).  
  9 
The spinal cord is generally considered as a non-neurogenic region in the CNS under 
normal condition or after injury (Barnabe-Heider et al., 2010; Horner et al., 2000; Shechter 
et al., 2007). However, a recent study showed that taking advantage of the new technique 
Div-sequencing which better preserves the integrity of neurons and their RNA content, 
19% of the analyzed proliferative cells are immature neurons which can be still detected up 
to 25 days or longer after survival in the spinal cord. Further analysis showed that these 
rare newborn neurons in the intact spinal cord are due to GABAergic neurogenesis (Habib 
et al., 2016). Although the function and the origin of these newborn neurons and the spinal 
cord neurogenesis capacity between young and aging animals are still not clear, this study 
opens a new way to study adult neurogenesis and provides more insights on the overlooked 
neural stem cell potential of the spinal cord.    
1.3 SPINAL CORD INJURY  
1.3.1 Scar formation and the response of neural stem/progenitor cells 
Spinal cord injury (SCI) leads to massive cell death and a loss of motor function and 
sensory inputs below the injury level. CNS intrinsic neural cells (neurons, astrocytes, 
OPCs, ependymal cells), CNS intrinsic non-neural cells (microglia, pericytes, etc.) and 
immune cells from the blood are affected by and respond to an injury differently (Burda 
and Sofroniew, 2014). Upon SCI, in the acute phase, the immediate damage of spinal cord 
leads to the loss of neurons and glial cells, including oligodendrocytes that should be 
remyelinating the surviving neurons. As a consequence, the loss of neurons after SCI leads 
to the dysfunction of the motor and sensory system (Ahuja et al., 2017). During the sub-
acute phase, inflammation and ongoing necrotic neurons and glial cells lead to the 
production and secretion of free radicals, chemokines, and cytokines that activate 
microglial cells (Ahuja et al., 2017). Together with other inflammatory cells such as 
activated macrophages, polymorphonuclear cells, and lymphocytes, microglia infiltrate the 
lesion site for further inflammatory response and contribute to ongoing apoptosis of 
neurons and oligodendrocytes (Ahuja et al., 2017; Hausmann, 2003). After the sub-acute 
phase of SCI, Wallerian degeneration, an ordered process of axonal death is undertaken 
(Alizadeh et al., 2015; Waller, 1850). After the injury on the nerve fiber, the axonal skeleton 
disintegrates, and the axonal membrane breaks apart, which leads to axonal degeneration 
and the release of myelin debris. Myelin debris has found to be the source of axonal 
regeneration inhibitors, such as neurite outgrowth inhibitor A (Nogo‑A), oligodendrocyte-
myelin, glycoprotein (OMgp) and myelin-associated glycoprotein (MAG) (Filbin, 2003). 
However, due to the slow infiltration of immune cells and the low capacity of 
oligodendrocytes to clear myelin, there is accumulation of myelin in the CNS tissue after 
injury. This accumulated myelin in turn leads to the apoptosis of oligodendrocytes and 
further contributes to the failure of remyelination and regeneration (Ahuja et al., 2017; 
Barres et al., 1993; Franklin and Ffrench-Constant, 2008; Vargas and Barres, 2007).  
Following SCI, a scar is formed, which is composed of a fibrotic component core and a 
glial scar surrounding it. The fibrotic lesion core is formed by perivascular cells, including 
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type-A pericytes (Goritz et al., 2011; Klapka and Muller, 2006; Soderblom et al., 2013), 
while the glial scar is generated by astrocytes derived from resident astrocytes and 
ependymal cells-derived astrocytes (Barnabe-Heider et al., 2010; Meletis et al., 2008).  The 
fibrotic scar is traditionally believed to be nonfunctional or have adverse long-term effects 
and impacts on axon regeneration (Burda and Sofroniew, 2014; Zukor et al., 2013). 
However, new studies have shown that the absence of type-A pericytes or ependymal cells-
derived astrocytes prevents the sealing of wound and therefore worsen SCI outcomes 
(Goritz et al., 2011; Sabelstrom et al., 2013). Moreover, even though it was widely believed 
that reactive astrocytes migrate to the injury site and contribute to glial scar formation, 
recent fate-mapping and live imaging studies showed that astrocytes do not migrate to the 
lesion site after SCI and most of the astrocytes are not migratory after brain injury (Bardehle 
et al., 2013; Tsai et al., 2012). Instead, astrocytes are under massive proliferation and 
upregulate the GFAP expression to further participate in the glial scar formation within 
their previous locations (Barnabe-Heider et al., 2010; Tsai et al., 2012). The function of the 
glial scar is under debate regarding its role in attenuating axonal regrowth, but it has been 
shown that the glial scar also serves as a barrier to block inflammation and immune cell 
infiltration to the lesion and prevent further tissue damage (Faulkner et al., 2004; Herrmann 
et al., 2008; Okada et al., 2006; Sabelstrom et al., 2013; Wanner et al., 2013). By impairing 
the formation of glial scar by transgenic mouse models to block cell cycle of astrocytes-
producing ependymal cells or to kill proliferative astrocytes, previous studies have shown 
that the significant loss of glial scar leads to worsened secondary injury to the tissue and 
the loss of axonal regeneration (Anderson et al., 2016; Sabelstrom et al., 2013).         
Neural stem/progenitor cells, including ependymal cells, astrocytes, and OPCs are highly 
proliferative after SCI and display different cellular responses (Figure 2). Ependymal cells 
were found to be the only cell type displaying multi-potency after SCI (Barnabe-Heider et 
al., 2010; Meletis et al., 2008). Ependymal cells rarely divide around the central canal and 
can only generate a small number of neurospheres in cell culture under physiological 
condition. After SCI, ependymal cells divide rapidly and differentiate into other glial cells 
in vivo, and these differentiated progenies leave the central canal and migrate to the lesion 
side. Half of the ependymal cells differentiate into astrocytes in the glial scar and also 
produce a few oligodendrocytes that myelinate axons (Barnabe-Heider et al., 2010).  
Moreover, ependymal cells from an injured spinal cord generate a significantly higher 
number of neurospheres in vitro and can be passaged on with higher self-renewal capacity 
than those from the non-injured condition. Differentiation assays showed that ependymal 
cell-derived neurospheres have higher potential to generate oligodendrocytes and neurons 
in vitro after SCI. This observation suggests that the stem cell potential of these neural stem 
cells is activated by SCI, regarding self-renewal and differentiation (Li et al., 2016/ Paper 
II). Resident astrocytes dramatically increase their proliferation after SCI and upregulate 
the expression of GFAP near the lesion site and surrounding area, forming part of the glial 
scar that prevents inflammation and the infiltration of immune cells. However, astrocytes 
can only give rise to more astrocytes and do not acquire stem cell potential after SCI, neither 
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in vivo nor in vitro (Barnabe-Heider et al., 2010). Unlike the astrocyte-derived astrocytes 
in the glial scar that forms a barrier to inhibit secondary tissue damage, ependymal cell-
derived astrocytes contribute to glial scar formation and reside in the center of the scar, 
surrounding fibroblast-like stromal cells that make up the core of the forming scar 
(Barnabe-Heider et al., 2010; Camand et al., 2004; Goritz et al., 2011; Krikorian et al., 
1981; Sabelstrom et al., 2013; Shearer and Fawcett, 2001; Windle and Chambers, 1950). It 
was shown that blocking the cell cycle of ependymal cells leads to enlarged cyst at the 
lesions, resulting in injuries growing deeper and an increased loss of neurons, partly due to 
the decreased production of neurotrophic factors by ependymal cells. These findings 
suggest that ependymal cells act as a scaffold to reinforce the injured spinal cord by 
restricting secondary enlargement of lesions (Sabelstrom et al., 2013). OPCs are the most 
proliferative glial cells in the intact spinal cord, and their proliferation is even more 
increased after SCI. OPCs and ependymal cells generate remyelinating oligodendrocytes 
after SCI, but OPCs cannot self-renew in vitro and do not give rise to other cell types in 
vivo. However, recent studies using transgenic lineage tracing mouse models showed that 
OPCs are the major cell type that contributes to new myelin formation following SCI (Hesp 
et al., 2015). OPCs also produce the majority of myelinating Schwann cells in the injured 
spinal cord, while the contribution to myelination by invading peripheral myelinating 
Schwann cells after SCI is very limited (Assinck et al., 2017).  
                      
Figure 2. The response of endogenous cells after SCI (dorsal funiculus lesion). After a dorsal funiculus 
lesion, the glial scar is formed with cells produced by ependymal cells (green), astrocytes (red) and pericytes 
(yellow). After SCI, the ependymal cells self-renew, differentiate, and the progeny migrate to the lesion site. 
Astrocytes (red), OPCs (blue) and pericytes (yellow) also self-renew and give rise to astrocytes, 
oligodendrocytes and stromal cells, respectively. Adapted from Sabelstrom et al., 2014.  
1.3.2 The regenerative potential of spinal cord cells after SCI over time  
Even though neural cells intensively respond to SCI with their specific potential, the self-
recovery potential of the spinal cord after injury seems to decline during aging (DeVivo et 
al., 1990; Furlan et al., 2010; Wyndaele and Wyndaele, 2006). It was reported that the 
potential of neural stem cells decreases during aging and in aged animals after traumatic 
brain injury, which is due to the quiescence but not loss of neural stem cells, and also due 
to the change of their differentiation potential (Bouab et al., 2011; Conover and Shook, 
2011; Sun et al., 2005). Indeed, astrocytes and ependymal cells significantly change their 
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morphology and molecular signatures during brain aging, and their proliferation capacity 
decreases over time (Capilla-Gonzalez et al., 2014). After SCI, there is a higher expression 
of astroglial and inflammatory markers near and at the lesion site in the aged animals, and 
the mammalian CNS undergoes an age-dependent decline in axonal regeneration and 
becomes less regenerative (Geoffroy et al., 2016).  
Besides the changes in the microenvironment, the intrinsic regenerative potential of 
stem/progenitor cells is also age-dependent. At a very young age (P10), all the spinal cord 
stem cell potential is entirely confined to ependymal cells, but the self-renewal capacity 
significantly decreases at the juvenile stage and even more in adulthood in mice. The 
differentiation capacity of ependymal-derived neurospheres to oligodendrocytes also 
declines over time (Li et al., 2016). Similarly, the recruitment and differentiation capability 
of OPCs in aged animals largely decrease (Hinks and Franklin, 2000; Kuhlmann et al., 
2008; Sim et al., 2002). These findings suggest that the self-recovery capacity decreases 
with increased aging is partly due to the decreased endogenous remyelination potential by 
ependymal cells and APCs (Figure 3; Paper II).   
After the insult to a spinal cord, astrocytes, ependymal cells and type A pericytes rapidly 
proliferate and contribute to the scar formation in adult (Barnabe-Heider et al., 2010; Goritz 
et al., 2011; Sabelstrom et al., 2013). At a younger age, these cell types are more 
proliferative and pro-regenerative compared to adult cells. After SCI, the stem cell potential 
of juvenile ependymal cells is more activated than those in adults in vitro, by showing 
greater self-renewal capacity and more oligodendrocyte differentiation. We found that 
similar lesions are sealed more efficiently in young animals compared to adults. Juvenile 
lesions have a smaller fibrotic core and smaller glial scar, as well as less infiltration of 
microglia and blood-derived macrophages (Figure 3). Interestingly, even though 
ependymal cells have a higher stem cell potential in juvenile mice, they are acting as a 
backup reserve and contribute to scar formation only when the lesion is larger and need 
more cells to be sealed (Li et al., 2016/ Paper II). Ependymal cells are required for 
restricting enlargement of the lesion in adult (Sabelstrom et al., 2013), but the same 
transgenic mouse model in which the cell cycle of ependymal cells is blocked showed a 
different phenotype in juvenile animals. The juvenile spinal cord is sealed so efficiently by 
other cells that blocking ependymal cell proliferation does not lead to deeper lesions nor 
the formation of a cyst at the lesion site. The area of glial scar and the lesion core are also 
smaller even when ependymal cells are not able to proliferate. This analysis is in line with 
the clinical studies that have shown that juveniles have better functional recovery than 
adults in human (DeVivo et al., 1990; Furlan et al., 2010; Wyndaele and Wyndaele, 2006).     
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Figure 3. Ependymal cells and resident cells respond to SCI. A) Under both physiological and injured 
conditions, ependymal cells show different self-renewal and differentiation potential in juvenile mice 
compared to adult mice in vitro.  B) The response of ependymal cells (green) is age- and lesion size-dependent. 
Response to SCI of other endogenous cell types is illustrated as follows: resident astrocytes (purple), immune 
cells (red) and pericytes (yellow). Adapted from Li et al., 2016.              
 
1.4 REGENERATIVE APPROACHES  
1.4.1 Modulating endogenous stem/progenitor cells  
Endogenous glial cells play important roles in maintaining homeostasis of the spinal cord. 
Even though OPCs are the most proliferative cell type throughout the entire parenchyma 
of the spinal cord, astrocytes and ependymal cells are also under massive proliferation after 
SCI and contribute to the self-repair of the spinal cord. 
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As astrocytes are the most numerous cells in the spinal cord, their function as glial scar 
forming component and their effects on recovery have been under substantial investigation. 
However, the potential and benefits of clinical applications by modulating astrocytes after 
SCI are still under debate. Indeed, the glial scar has been long time considered as a barrier 
for axonal regeneration by inhibiting axonal regrowth (Fawcett, 2006; Okada et al., 2006; 
Sofroniew, 2009), while there is an increasing number of studies showing the beneficial 
effects of glial scar for tissue repair (Anderson et al., 2016; Burda and Sofroniew, 2014)  
but the latter studies are still facing challenges (Silver, 2016). Using conditional knockout 
strategies to genetically manipulate genes expressed by astrocytes, such as Stat3 and Soc3, 
can influence the glial scar formation and functional recovery after SCI with different 
effects (Herrmann et al., 2008; Okada et al., 2006). Conditional ablation of Stat3 results in 
limited migration of astrocytes and widespread infiltration of inflammatory cells, neural 
disruption and demyelination with severe motor deficits, whereas the loss of Soc3 leads to 
rapid migration of reactive astrocytes to seclude inflammatory cells, enhanced contraction 
of lesion area and notable improvement in functional recovery (Herrmann et al., 2008; 
Okada et al., 2006). However, most of the studies above used Nestin or GFAP promoter to 
genetically modulate almost the entire population of reactive astrocytes after SCI, which 
makes it difficult to draw specific conclusion. Indeed, recent studies showed that spinal 
cord astrocytes are very phenotypically and functionally heterogeneous in the CNS and 
after SCI (Bardehle et al., 2013; Tsai et al., 2012). Blocking the subtype of astrocytes 
derived from ependymal cells after SCI for instance, leads to a more severe lesion and 
worsen functional recovery (Sabelstrom et al., 2013). Therefore, further investigation 
should be undertaken to target different subpopulations of astrocytes and understand the 
role and composition of the glial scar for a better clinical translation.    
As previously discussed in this thesis, after the acute phase of SCI, Wallerian degeneration 
takes place, which is a process of ordered axonal death, resulting in the continuous death 
of demyelinating neurons and oligodendrocytes (Ahuja et al., 2017; Waller, 1850). 
Therefore, Wallerian degeneration leads to functional loss after SCI and remyelination have 
been proposed as a crucial strategy for functional recovery (Plemel et al., 2014). Fate 
mapping experiments have shown that OPCs are under massive proliferation and 
differentiate into mature oligodendrocytes after SCI, and contribute to remyelination 
(Assinck et al., 2017; Barnabe-Heider et al., 2010; Hesp et al., 2015; Sellers et al., 2009). 
Moreover, NG2+ OPCs undergo substantial proliferation after SCI and generate myelin for 
several months in rats (Hesp et al., 2015), consistent with another study showing that OPCs 
from PDGFRα-driven reporter mice start to produce myelin from one month and up to three 
months after SCI (Assinck et al., 2017). These studies suggest that modulating the 
proliferation, differentiation and remyelination efficiency of OPCs could be a way to 
improve functional recovery. However, the spontaneous reactivity of OPCs is apparently 
not sufficient to obtain functional recovery. Moreover, age affects the recruitment and 
differentiation of OPCs. A recent study showed that rejuvenation of OPCs restored the 
regeneration capacity in mice due to the induced youth environment, which suggests that 
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remyelination-enhancing therapies targeting endogenous cells can be effective throughout 
life (Ruckh et al., 2012). Even though the mechanisms behind oligodendrogenesis and 
remyelination are still under investigation, many studies showed that growth factors 
playing a role in promoting proliferation of OPCs during development could be useful after 
SCI, such as basic fibroblast growth factor (bFGF), insulin growth factor 1 (IGF1), ciliary 
neurotrophic factor (CNTF), glial growth factor (GGF) (Plemel et al., 2014). Furthermore, 
treating mice after with GGF or GGF/FGF increases not only OPC proliferation but also 
results in improved functional recovery in injured mice (Whittaker et al., 2012). Other 
strategies, such as targeting extracellular inhibitors of remyelination, inflammatory cells 
and hormones are also suggested by many studies for potential therapeutic applications 
(Plemel et al., 2014).     
Ependymal cells have been discovered as the only endogenous stem cells in the spinal cord 
from P10 to adulthood and were suggested as a cell type that can be modulated for non-
invasive therapies without the risk of surgical or immune-rejection complications 
(Barnabe-Heider et al., 2010). Furthermore, as the stem cell potential of ependymal cells 
has been fully developed since early postnatal age, ependymal cell-based therapies may be 
used regardless of the age of patients (Li et al., 2016/ Paper II). As ependymal cells are 
capable to differentiate into astrocytes that are required for reinforcing the injured spinal 
cord (Barnabe-Heider et al., 2010; Sabelstrom et al., 2013) and give rise to 
oligodendrocytes that may benefit remyelination (Barnabe-Heider et al., 2010), it gives 
hope that modulating ependymal cells may contribute to the development new therapies. 
Even though the molecular mechanism behind the response of ependymal cells to SCI is 
still mostly unknown, recent studies using transgenic mice have shown that proteins such 
as FoxJ1 and β1-Integrin expressed by ependymal cells regulate the stem cell potential or 
the contribution of ependymal cells to glial scar formation (Li et al., 2018; North et al., 
2015). Therefore, it is worthy to investigate this cell type further and consider targeting 
them for gene and cell therapies.   
1.4.2 Cell transplantation therapies  
Even though studies on endogenous stem cells and progenitor cells have shown beneficial 
effects in experimental and pre-clinical studies, the mechanisms behind these findings need 
further elucidation. Cell transplantation, on the other hand, has been extensively studied 
since 20 years (Houle and Reier, 1988; Kunkel-Bagden and Bregman, 1990; Liu et al., 
2000; Ramon-Cueto, 2000). Although there are a number of challenges for clinical 
applications, cell transplantation-based therapies have given some promising results for 
patients with SCI.  
One of the most common cell types for transplantation in SCI studies is mesenchymal stem 
cells (MSCs). MSCs can be isolated from different sources, including bone marrow, 
umbilical cord, amniotic liquid and adipose tissue. Advantages of using MSCs include the 
possibility of autologous transplants to avoid rejection and immune-suppression. 
Moreover, this approach overcomes ethical concerns compared to the use of embryonic 
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stem cells (Dasari et al., 2014). Animal studies have shown that MSC transplantation plays 
an anti-inflammatory protective role and suppresses the activity of immune cells (Caron et 
al., 2016; Chua et al., 2010; Neirinckx et al., 2014). Further cellular damages by SCI can 
be reduced as a result of MSC transplantation, partly due to the secretion of trophic factors 
by MSCs, including vascular endothelial growth factor (VEGF), nerve growth factor 
(NGF), glial cell-derived neurotrophic factor (GDNF) and brain-derived neurotrophic 
factor (BDNF) (Neirinckx et al., 2014). Clinical trials have also shown that SCI patients 
after MSC transplantations gain motor and sensory improvements based on the clinical 
score of American Spinal Injury Association, electromyography and magnetic resonance 
imaging (Dai et al., 2013; El-Kheir et al., 2014; Jarocha et al., 2015; Jiang et al., 2013; Li 
et al., 2015).  
Embryonic stem cells (ESCs) could compensate for the massive cell loss after SCI by their 
multipotency to differentiate into neurons and glial cells. ESCs for transplantation therapies 
can be obtained from embryonic tissues or clonally derived from ESC cultures. ESCs are 
capable of differentiating into neuronal cells and glial cells upon transplantation, as well as 
produce factors that can prevent further damage and sustain endogenous tissue 
regeneration. Animal studies showed that transplanted ESCs can differentiate into neurons 
(Iwai et al., 2015; Johnson et al., 2010; Salewski et al., 2015; Yang et al., 2013) or 
oligodendrocytes (All et al., 2015; Sun et al., 2013) in SCI models, and promote significant 
motor functional recovery (Iwai et al., 2015; Johnson et al., 2010; Salewski et al., 2015; 
Yang et al., 2013). A clinical trial using oligodendrocytes-derived from ESCs for SCI 
patients was planned, but the study was terminated due to fund issues (Frantz, 2012). 
Recently, a new protocol showed that using human ESC-derived neural stem cells can 
differentiate into diverse neuronal and glial fates in vitro, and that functional recovery after 
SCI is improved significantly after grafting the derived NSCs to the rats with SCI 
(Kumamaru et al., 2018). Despite the significant efficacy of ESC transplantation in pre-
clinical studies, ethical concerns and the uncontrollable side effect of teratoma formation 
limits the potential clinical applications of ESCs (Herberts et al., 2011; King and Perrin, 
2014).   
Neural stem cells (NSCs) can be isolated from stem cell niches in the CNS, including 
subventricular zone and the hippocampus of the brain, and the central canal of the spinal 
cord (Weiss et al., 1996). Transplanting NSCs into injured spinal cords improved highlimb 
motor and sensory recovery, and neuronal cell replacement was able to reduce the loss of 
neural cells with the support of trophic factors (Hawryluk et al., 2012; Hofstetter et al., 
2005). Moreover, the first preclinical trial was recently performed with NSC cell line NSI-
566, which is derived from a single post-mortem spinal cord of an 8-week gestational age 
fetus (Curtis et al., 2018). It has been shown that the transplantation of NSI-566 cells into 
both SCI patients and animals is safe and no serious adverse events were found. Two 
patients with transplantation treatments had a certain level of functional recovery (Curtis et 
al., 2018). Even though clinical trials have shown that NSC transplantation into the injury 
site of SCI patients is safe, it has not been well documented for recovery outcomes in a 
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large scale, and there was a lack of control group; thus further studies need to be done 
(Curtis et al., 2018). Moreover, these NSCs cannot be obtained from the same patient, 
leading to heterologous transplantations and the need for immunosuppression (Barnabe-
Heider and Frisen, 2008; Curtis et al., 2018).  
The discovery of induced-pluripotent stem cells (iPSCs) has provided promising medical 
applications with a lower risk of rejection and without leading to serious ethical concerns 
regarding the use of embryos. Recent animal studies have shown compelling evidence that 
iPSC transplantation or iPSC-derived NSC transplantations are safe. Grafted cells give rise 
to neuronal cells and oligodendrocytes and integrate into the neural network, and some of 
the studies show motor recovery after transplantation (All et al., 2015; Kawabata et al., 
2016; Kobayashi et al., 2012; Lu et al., 2014; Nori et al., 2011; Romanyuk et al., 2015; 
Salewski et al., 2015). However, other studies suggested that further investigations need to 
be carried out before clinical trials, as iPSCs and ESCs share similar characteristics and 
may lead to teretoma formation (Barnabe-Heider and Frisen, 2008; Khazaei et al., 2016). 
Besides transplantation strategies using stem cells for beneficial molecules or the 
replacement of lost cells, autologous glial cell transplantation also leads to improved 
outcomes after SCI. Specifically, olfactory ensheathing cells (OECs) which are located in 
the olfactory system are one of the candidates. OECs support and guide axonal growth from 
the peripheral nervous system to the CNS during development, adult neurogenesis or 
axonal regeneration. Therefore, it has been hypothesized that OECs could facilitate CNS 
axon regrowth after injury (Barnett and Chang, 2004; Barnett and Riddell, 2007; Franssen 
et al., 2007). OECs can be obtained from the olfactory bulb or olfactory mucosa of the same 
patient of SCI. Animal studies have shown that transplantation of OECs after SCI in rodents 
promotes functional recovery (Lakatos et al., 2000; Polentes et al., 2004; Ramon-Cueto et 
al., 1998; Stamegna et al., 2011; Yamamoto et al., 2009). The mechanisms behind these 
observations are probably because OECs secrete many neurotrophic factors, such as 
BDNF, GDNF, VEGF, NT-3, etc (Yang et al., 2015). Even though OECs from different 
sources can promote axonal regeneration and neuroprotective effects at different extent 
after being transplanted into the injured spinal cord, subpopulations of OECs display 
different cellular and molecular characteristics (Guerout et al., 2010; Honore et al., 2012). 
The observations may further lead to variations in the transplantation effects. Indeed, 
transplantation of OECs obtained from different regions leads to various recovery 
outcomes: for instance, olfactory bulb-derived OECs have been shown to have better 
effetcs on motor nerve repair (Paviot et al., 2011). Recent clinical trials showed that 
transplantation of OECs to a patient, who suffered traumatic transection of the thoracic 
spinal cord at upper vertebral level Th9, induced axon elongation and functional recovery 
(Tabakow et al., 2013; Tabakow et al., 2014). Another clinical study, using mucosa-derived 
OEC transplantation, reported enhanced recovery but with profoundly different scores 
based on individuals (Wang et al., 2016a). As OECs are highly differentiated cells in 
comparison to ESCs, OEC transplantation upon SCI overcomes the risk of teretoma 
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formation (Gomez et al., 2018). The main strategies using cell transplantation therapies 
upon SCI is summarized in Figure 4 below.  
Even though many studies have given promising insights into the mechanism of effects by 
which OEC transplantation affects SCI recovery positively regarding factor secretion and 
axonal guidance, little is known about the effects on the regenerative capacity of 
endogenous stem/progenitor cells after OEC transplantation. Using the transgenic mouse 
line FoxJ1-CreERT2-YFP to specifically fate map and trace ependymal cells and their 
progeny, we found that transplantation of olfactory bulb-OECs (bOECs) after SCI can 
enhance proliferation of ependymal cells in vivo and self-renewal capacity in vitro. 
Furthermore, bOECs promote astrocytic differentiation from ependymal cells but reduce 
the expression of axonal regrowth inhibitors, such as CSPGs and Neurocan. Using FoxJ1-
CreERT2-Rasless mice to block the cell cycle and the proliferation of ependymal cells 
specifically, we found that bOEC can rescue the enlarged wound occurring due to the lack 
of the contribution of ependymal cell progeny to the lesion site (Sabelstrom et al., 2013; 
Paper III). Interestingly, we found that bOEC transplantation can promote adult 
neurogenesis after SCI, which has not been reported before (Paper III). Our data suggest 
that bOEC transplantation stimulates endogenous stem/progenitor cells, leading to 
beneficial effects on recovery of the injured spinal cord. Further studies are carried out to 
understand the molecular mechanisms occurring after bOEC transplantations, which could 
be modulated to increase their recovery efficiency.  
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Figure 4. Strategies using cell therapies for SCI. A) The main cellular targets and putative mechanism of 
action of cell-based approaches in mammalian spinal cord after SCI. B) The stem cell-based and glial cell-
based mechanisms driving anti-inflammatory and pro-regenerative processes after SCI. Adapted from 
Vismara et al., 2017. 
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2 AIMS OF THE THESIS  
The goal of this thesis is to understand the regenerative potential of endogenous spinal 
cord stem/progenitor cells during spinal cord development, after spinal cord injury, and 
after cell therapy. The specific aims are: 
 To understand the FoxJ1+ spinal cord progenitors during development and after 
spinal cord injury; 
 To study the different stem cell potential of ependymal cells before and after 
spinal cord injury from juvenile to adulthood; 
 To elucidate the cellular effect of bulbar olfactory ensheathing cell 
transplantation on the injured spinal cord  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 22 
3 MATERIALS AND METHODS  
3.1 ANIMALS  
All experiments performed in Karolinska Institutet were conducted following the 
guidelines of the Swedish Board of Agriculture (ethical permit N329/11, N217/14) and 
were approved by the Karolinska Institutet Animal Care Committee. All experiments 
conducted in France were under the permit by the French Ministry of Agriculture, 
Agrifood, and Forestry and were approved by the committee of the French Ministry of 
Higher education and Research. 
FoxJ1::EGFP 
We used FoxJ1::EGFP mice to label FoxJ1+ cells in the developing spinal cord. In this 
transgenic mouse line, enhanced green fluoresce protein (EGFP) is driven by the human 
FoxJ1 promoter without tamoxifen induction (Ostrowski et al., 2003).   
FoxJ1-CreERT2-YFP 
We used tamoxifen-inducible FoxJ1-CreERT2-YFP transgenic mice (Barnabe-Heider et al., 
2010; Li et al., 2018; Li et al., 2016; Meletis et al., 2008) to lineage trace the FoxJ1+ cells 
during development, and specifically fate map ependymal cells after SCI. Several neural 
cell populations highly express the FoxJ1 promoter during spinal cord development and 
exclusively by ependymal cells in the adult spinal cord.  
FoxJ1-CreERT2-KI-TdTomato  
We used a knock-in mouse model to study the effect of FoxJ1 during spinal cord 
development and after SCI. By inserting a sequence of CreERT2, Muthusamy et al. 
specifically disrupted sequence of an exon of foxj1 gene, which leads to the FoxJ1 
knockout effect (Muthusamy et al., 2014). We crossed this mouse model with Rosa26-
TdTomato mice to further label the FoxJ1 promoter active cells which are FoxJ1+/- or 
FoxJ1-/- at specific time points. FoxJ1-/- mice are postnatally lethal due to the loss of FoxJ1 
(Muthusamy et al. 2014).   
FoxJ1-CreERT2-Rasless-YFP  
We used FoxJ1-CreERT2-Rasless-YFP mice by crossing FoxJ1-CreERT2, Rosa 26-YFP 
and Rasless mice where the N-, H-ras genes are homogenously knockout, and K-ras gene 
is between loxP loci. After tamoxifen administration, the cell cycle of ependymal cells is 
blocked due to the loss of three ras genes while the ependymal cells are labeled with YFP 
(Sabelstrom et al., 2013).  
Connexin 30-CreERT2-YFP 
We Connexin 30-CreERT2-YFP mice to specifically label spinal cord astrocytes after SCI 
and after transplantation treatments (Slezak et al., 2007). After tamoxifen administration, a 
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large population of astrocytes in the spinal cord is labeled by YFP, allowing us to lineage 
trace them and their progeny.  
hGFAP-CreERT2-YFP 
We hGFAP-CreERT2-YFP mice (Ganat et al., 2006) to label spinal cord astrocytes after 
SCI and after transplantation treatments, complementary to the Connexin 30-CreERT2-
YFP mice. After tamoxifen administration, a large population of astrocytes in the spinal 
cord is labeled by YFP, allowing us to lineage trace them and their progeny.  
GLAST-CreERT2-YFP  
We GLAST-CreERT2-YFP mice to label a subtype of astrocytes and progenitors in the 
spinal cord to study their responses after SCI and after transplantation treatments (Mori et 
al., 2006). After tamoxifen administration, OPCs in the spinal cord are labeled by YFP, 
allowing us to lineage trace them and their progeny. 
PDGFRα-CreERT2-YFP  
We PDGFRα-CreERT2-YFP mice to label spinal cord OPCs after SCI specifically and after 
transplantation treatments (Rivers et al., 2008). After tamoxifen administration, OPCs in 
the spinal cord are labeled by YFP, allowing us to lineage trace them and their progeny. 
For recombination induction, we injected Tamoxifen at 60 mg/kg of body weight once per 
day for 5 and 3 days in adult and juvenile mice, respectively. Five days of clearance time 
allowed the undetectable level of tamoxifen before the start of the SCI experiments. 
Embryonically and early postnatally, pups’ dams were given tamoxifen intraperitoneal 
injection (60 mg/kg) or gavage to pregnant mice (50 mg/kg) from embryonic day E13-14, 
E15-17, E17-18, postnatal day P0-P4 and P5-P9. These animals were sacrificed one day 
after the last injection.  
To label proliferative cells and their progeny, EdU (0.075 mg/ml and 1% sucrose) was 
administered in drinking water, exchanged twice per week and kept in the dark. After spinal 
cord injury, EdU was given twice by intraperitoneal injections (1.5 mg/ml, 100µl per 
injection) at 6 hours interval, followed by EdU administration in the drinking water for 7 
days.  
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Figure 5. Schematic illustrations of transgenic mouse models used in this thesis.  
 
3.2 SURGICAL PROCEDURE AND POSTOPERATIVE CARE  
3.2.1 Spinal cord injury 
Mice were kept under anesthesia with a mixture of 5% isoflurane (Baxer) at the starting 
point then at 2% isoflurane and 1 liter/minute O2 during surgery. Animals were kept on a 
thermo-pad for the entire surgery to maintain the body temperature around 37-38°C. The 
back of the animal was shaved and disinfected with 70% EtOH. The skin was incised, the 
superficial fat gently shifted, and the muscle tissue dissected to expose laminae T9 –T11. 
Laminectomy was performed at the T10 level, and the dura mater was removed. A dorsal 
funiculi transection or a dorsal hemisection were performed with a micro knife (FST). 
3.2.2 Transplantation of olfactory ensheathing cells  
Experiments regarding cell transplantation in paper III followed SCI. Bulbar olfactory 
ensheathing cells were isolated and dissociated manually from 10-day bOEC culture, and 
approximately 50,000 cells (25,000 cells/ µL with 2 µL/ injection) or DF10S media as 
control were transplanted into the spinal cord near the midline at around 1 mm depth, 1.5 
mm from the midline, 5 mm rostral and caudal to the lesion by a 1 mm sterile glass capillary 
needle, respectively. Injections were slowly delivered within 1 min, followed by holding 
the needle at the injection site for 2 min and carefully withdraw the injection needle.  
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After the surgical process, the wounds were sewed, and mice were placed back in their 
home cages. Mice underwent a daily check for general health, mobility within the cage, 
wounds, swelling, infections, or autophagy of the toes. The animals showed neither skin 
lesions, infection, nor autophagy throughout the study. Bladders were manually expressed 
after operation until unneeded.  
3.3 TISSUE PREPARATION AND SECTIONING 
For embryo tissues, embryos were collected and fixed in 4% PFA in PBS for at least 12 
hours and up to 2 days, then transferred to 30% sucrose solution for at least 2 days up to 1 
week. For embryos older than E14, the spines were dissected and isolated after PFA 
fixation and were transferred to 30% sucrose solution at 4°C for at least 2 days and up to 1 
week. 
For neonatal mice, pups were decapitated at post-natal day 0 (P0) –P10. Spines were placed 
in 4% PFA for one day then the spinal cords were dissected out from the spines. The spinal 
cords were then placed in 4% PFA at 4°C in PBS for 1-2 days, followed by transfer in a 
30% sucrose solution and kept at 4°C for at least two days. 
For adult spinal cords, the animals were deeply anesthetized with sodium pentobarbital 
(APL) (150 mg/kg body weight) and perfused transcardially with 0.1 M PBS, pH 7.4, then 
4% PFA in PBS, pH 7.4 (Life Technologies). Spinal cords were dissected out from the 
perfused animals and were further post-fixed in 4% PFA in PBS at 4°C overnight and 
cryoprotected in 30% sucrose (Life Technologies) for at least 48 h. After embedding in 
Tissue-Tek OCT compound (Sakura), the spinal cords were cryosectioned sagittally or 
coronally to 16-20 micron thickness. Sections were collected 1:12 accordingly to 
stereological principles and stored at -80°C until further use.  
3.4 IN SITU HYBRIDIZATION (ISH) 
ISH was performed to detect mouse FoxJ1 mRNA following previously published method 
(Pineau and Lacroix, 2007). Basically, a coding sequence of 831 base pairs matching only 
the Foxj1 gene, as verified by BLAST analysis in Genbank, was amplified by polymerase 
chain reaction (PCR) from a C57BL/6 mouse brain cDNA library using the same primers 
used in the Allen Developing Mouse Brain Atlas (forward 5’-
ACATCAACTGCCCTGCTACCT-3’; reverse 5’-CTAGCGGGCTTAGAGACCATTT-
3’). The amplicon was cloned into the pCR-Blunt II expression vector (Thermo Fisher 
Scientific Inc.). Radiolabeled cRNA probes were transcribed from linearized cDNAs using 
the Riboprobe Combination System SP6/T7 (Promega Corporation) in the presence of both 
[S35]-UTP and [S35]-CTP (Perkin Elmer). Sections of brain and spinal cord were pre-
hybridized, hybridized and post-hybridized as previously shown (Pineau and Lacroix, 
2007), except for the step in which sections were permeabilized with proteinase K. Instead, 
a 1.25 mg/mL (~0.0025 U/mL) solution of proteinase K was made and tissue sections 
digested for 5 minutes for spinal cords and 10 minutes for brains. 
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All images were acquired using a QIClick™ CCD Camera (QImaging) installed on a Nikon 
Eclipse 80i microscope. 
3.5 CELL CULTURE  
3.5.1 Neural stem cell culture and neurosphere assay  
Embryos and postnatal animal were sacrificed for control neurosphere culture. Spinal cord 
cells were dissociated, and neurosphere cultures were based on the established protocol as 
described (Li et al., 2018; Li et al., 2016; Meletis et al., 2008).  
For the embryonic stages, spinal cords were dissected and dissociated manually, and one 
small cervical biopsy per animal was kept in 4% PFA for one day then transferred to 30% 
sucrose solution at 4 °C until further use. Dissociated cells were plated in either in 10 cm 
petri dish (with 10ml culture medium) or T75 flasks (with 30ml culture medium). Postnatal 
animals were sacrificed and dissected for the spinal cord. Papain solution and DNase I 
enzyme were used for cell dissociation (Meletis et al., 2008). All cells isolated from one 
postnatal animal spinal cord were plated in one 10 cm culture dish (with 10 ml culture 
medium) or a T75 flask (with 30 ml culture medium), depending on the needs. First 
neurospheres were collected after two weeks for quantification. Then the harvested primary 
neurospheres were dissociated manually into single cells for next generations of 
neurospheres or differentiation. During the passage, approximately 100,000 cells per flask 
(per animal) were seeded in either 10 cm culture dish or T25 flask. The passaged 
neurospheres (second, third and fourth generation) were collected and quantified after one 
week in culture. The differentiation assay is described below. Before the dissociation of the 
neurospheres, 1 ml medium containing the spheres (4 random selections of 250 ml 
medium) from each dish/flask were seeded into pre-coated slides (poly-L-lysine or poly-
D-lysine) for 12 hours’ culture for the analysis of recombination. The groups under the 
same analysis used the same culture system, including dishes or flasks, coating solution, 
reagents, etc.  
3.5.2 Differentiation assay  
Dissociated primary neurospheres, approximately 50,000 cells/well or 70,000 cells/well, 
depending on the proliferation rates of different ages, were plated in poly-D-lysine-coated 
or poly-L-lysine-coated chamber slides (Sigma) for differentiation with growth factors free 
medium supplemented by 1% fetal bovine serum. After ten days of differentiation, 
differentiated cells were fixed with 4% PFA for 20 minutes, followed by 
immunocytochemistry and data analysis. Two to four independent experiments per group 
were performed. 
3.5.3 Bulbar olfactory ensheathing cell culture  
The olfactory primary culture was prepared as previously described (Guerout et al., 2010) 
with slight modifications. Mice were sacrificed by a lethal dose of Thiopental and 
decapitated. OB was immediately dissected and placed into Hank's buffered salt solution 
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(HBSS) with 0.1% of trypsin (Invitrogen) after removing meninges. OBs were incubated 
for 20 min at 37°C. DF-10S medium, including Dulbecco's Modified Eagle's/Ham's F12 
medium (DMEM/F12, Invitrogen), supplemented with 10% Fetal Bovine Serum (FBS, 
Invitrogen) and 0,5% penicillin/streptomycin (Invitrogen) was used to terminate the effects 
of trypsin. The tissue solution was centrifuged, and pellets were then triturated with a 
micropipette until a homogenous cell suspension was obtained. Cells were plated in DF-
10S in T75 flasks (SARSTED). The flasks were incubated at 37°C, 5% CO2. The medium 
was changed every two days. Ten days after plating, bOECs were confluent. Before 
surgery, bOECs were detached from flasks treated with trypsin and the cells were counted 
with a hemocytometer. The bOECs were resuspended in DF-10S at the concentration of 25 
000 cells/µL. Medium culture DF-10S was used for control groups.  
3.6 IMMUNOHISTOCHEMISTRY AND IMMUNOCYTOCHEMISTRY 
Immunohistochemistry  
Full details of the primary antibodies used are reported in Table 1.  
Blocking solution was made with 10% normal donkey serum (Jackson Immunoresearch), 
0.3% Triton X 100 (Sigma) in 1X PBS. Blocking solution was applied to tissues for one 
hour at room temperature. Dilution of primary and secondary antibodies was performed 
with 2% BSA (Bovine serum albumin; Sigma), 0.2% Triton X100 PBS. Primary antibodies 
were incubated at room temperature overnight while secondary antibodies were incubated 
for 1 hour after two times washing with 1X PBS. Secondary antibodies were conjugated 
with Alexa Fluor fluorophores. Counterstaining was performed with DAPI (1: 10,000) in 
PBS and sections were coverslipped with Vectashield mounting media (BioNordika). EdU 
was detected with the Click-iT® EdU Alexa Fluor® 594 imaging kit (Invitrogen) using the 
Manufacturer’s instructions. Antibodies are described in Table 1. Secondary antibodies 
(A488, cy3, and cy5) are all from Jackson Immuno Research with host donkey. 
Immunocytochemistry 
After ten days' differentiation assay, differentiated cells were analyzed by 
immunocytochemistry for quantification. Recombined neurospheres or differentiated cells 
were stained with primary antibodies at room temperature overnight, followed by 
secondary antibodies for 1h at room temperature. Antibodies are described in Table 1. 
Secondary antibodies (A488, cy3, and cy5) are all from Jackson Immuno Research with 
host donkey. 
3.7 IMAGE ACQUISITION AND TISSUE ANALYSIS 
Confocal representative images of the lesion site and spinal cords were acquired using the 
Zeiss LSM700 or Zeiss LSM800 microscope set up. Quantification of the lesion and cell 
infiltration areas was performed using the Zeiss AxioSkop2 microscope set up and 
AxioVision software.  
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For embryo samples, regions along the rostral-caudal axis (cervical, thoracic and lumbar 
area) and different regions in coronal sections, including grey matter, central canal, lateral 
white matter, dorsal white matter and floor plate were quantified individually. The tissue 
quantification was performed on at least three sections per domain and per area. For each 
experimental group and staining, 3-9 animals were analyzed. For SCI samples, the areas 
were measured at the epicenter of the lesion and sections rostral and caudal to the injury 
site. SCI and transplantation studies used both coronal and longitudinal sections for 
analysis. For cell culture analysis, 6-8 randomly selected views per well were used for 
analysis, and at least three wells per animal were used for statistical analysis. Quantification 
of the number of cells was performed using the Zeiss Apotome2 microscope set up. The 
quantification of cells was performed in 2-4 sections per animal. For each experimental 
group and staining, 3-9 animals were analyzed. 
3.8 QPCR  
Real-time PCR experiments were performed to evaluate the level of mRNA expression of 
the axon growth inhibitory, axon growth permissive molecules and also neurotrophic 
factors (Anderson et al., 2016; Sabelstrom et al., 2013). Mice were sacrificed two weeks 
after SCI, and spinal cord was immediately dissected on ice. Total RNAs were extracted 
with Tri-reagent (Sigma) and Nucleospin RNAII kit (Macherey-Nagel) according to the 
manufacturer's protocol. From each sample, 1.5 μg of total RNA was converted into single-
stranded cDNA using the ImPromII reverse transcriptase kit (Promega) with random 
primers (0.5μg/ml). Real-time PCR experiments were performed and monitored by ABI 
Prism 7500 Sequence Detection System (Life Technologies). The primer pairs used for the 
different genes analysis have been previously described (Anderson et al., 2016; Sabelstrom 
et al., 2013). 
Mouse glyceraldehydes-3-phosphate dehydrogenase (GAPDH) cDNA was used as the 
control. Relative expression between a given sample and a reference sample was calculated 
using the 2-∆Ct method, where ∆Ct is the difference in the Ct values for the target gene 
and the reference gene. 
3.9 DRONC-SEQ SINGLE NUCLEUS SEQUENCING   
Mouse spinal cords two weeks or 3 months after SCI with or without bOEC transplantation 
were isolated from sacrificed animals and were frozen at -80°C. Samples were shipped on 
dry ice to Broad Institute, the USA for DroNc-seq, which was described in the published 
protocol (Habib et al., 2017). 
3.10 STATISTICAL ANALYSIS 
Statistics were run with Student's T-test for comparing two groups and Student's T-test with 
Bonferroni's correction for more than two groups' comparisons. For all the data analysis, 
Student's t-test with or without Bonferroni's correction or One-way ANOVA with 
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Bonferroni's Multiple Comparison was used as indicated. *P<0.05, **P<0.01, ***P<0.001. 
For each experimental group and staining, 3-9 animals were analyzed. 
Antibody Species Dilution Company (Catalog number) 
Chx10 Sheep 1:500 Millipore (AB9016) 
CNPase Mouse 1:200 Millipore (MAB326R) 
DAPI  1:10000 Sigma (D9542) 
Double cortin Goat 1:150 Santa Cruz (sc-8066) 
EVX1 Guinea pig 1:200 Gift from Dr.Alessandra Pierani 
Fox3 (NeuN) Rabbit 1:500 Atlas Antibodies (HPA030790) 
FoxJ1 Goat 1:200 R&D Systems (AF3619) 
GFAP Rabbit 1:500 Millipore (AB5804) 
GFP Chicken 1:500 Aves (GFP-1020) 
Iba1  Rabbit 1:500 Wako (019-19741) 
Ki-67 Rabbit 1:200 ThermoScientific (RM-9106) 
Neurocan Mouse  1:200 Sigma (N0913) 
NG2 Rabbit 1:200 Millipore (AB5320) 
Pax2 Rabbit 1:500 Life technologies (71-6000) 
PDGFR-β  Rabbit 1:200 abcam (ab32570)  
Reelin Mouse 1:200 Millipore (MAB5364) 
Sox10 Goat 1:500 R&D Systems (AF2864) 
Sox9 Goat 1:500 R&D Systems (AF3075) 
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Tuj1 Mouse 1:500 Covance (MMS435P) 
Vimentin Chicken 1:500 Millipore (AB5733) 
Table1. Primary antibodies used in the studies of this thesis.  
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4 RESULTS & DISCUSSION  
4.1 FOXJ1 IS REQUIRED FOR SPINAL CORD DEVELOPMENT AND THE 
MAINTENANCE OF SPINAL CORD STEM CELL POTENTIAL  
FoxJ1 is a transcription factor that is usually considered involved in ciliogenesis during 
development (Clevidence et al., 1994; Hackett and Weller, 1995; Murphy et al., 1997; 
Stubbs et al., 2008; Yu et al., 2008). In the spinal cord, FoxJ1 has been widely used as a 
marker to label ependymal cells, the only spinal cord stem cells in adult mice, to study their 
potential after SCI (Barnabe-Heider et al., 2010; Li et al., 2016; Meletis et al., 2008; North 
et al., 2015; Sabelstrom et al., 2013). However, we found that FoxJ1 is transiently expressed 
in other cell types than ependymal cells in the developing spinal cord. Indeed, using in situ 
hybridization, we found that foxj1 mRNA expression is not restricted around the central 
canal, but also along the entire ventricular zone and appears since E10, earlier than the first 
appearance of ependymal cells at E15. Our FoxJ1 immunostaining on WT mice also shows 
that FoxJ1 expression is along the ventricular zone, earliest found at E12-E13, suggesting 
that FoxJ1 is transiently expressed in neural progenitors during development.   
To study the migration of FoxJ1+ progenitors during development, we then used 
FoxJ1::EGFP mice as a short-term fate-mapping tool to label the FoxJ1 lineage cells, as 
the half like of EGFP is usually longer than transcription factors. We found that the progeny 
derived from FoxJ1+ progenitors are distributed in gray matter and floor plate since E10, 
then their distribution expands to central canal, lateral and dorsal white matter during 
neurogenesis and gliogenesis from E10-E17 with different morphology. However, EGFP+ 
cells drastically decreased and eventually are restricted to the central canal since P10.  
To characterize the cell types derived from FoxJ1 lineage, we used proliferative marker 
Ki67 and neuron/interneuron markers NeuN, EVX1, PAX2 and Chx10 during 
neurogenesis, and used other glial markers including Sox9, Vimentin, Reelin, and GFAP 
during gliogenesis for the EGFP+ cells. The expression pattern of transcription factors of 
interneuron development shows that Pax2 is widely expressed by various type of V1 
interneurons, while EVX1 and Chx10 are neatly expressed in the regions of V0 and V2 
interneurons respectively at E10 (Alaynick et al., 2011). We observed that the EGFP+ cells 
in the gray matter during neurogenesis (E10-13) are V1 and V2 interneurons, as many of 
them are co-labeled with PAX2 and a small number with Chx10. During gliogenesis (E15-
E18), we found that the number of EGFP+ interneurons decreased, but the other EGFP+ 
cells with increasing numbers are subpopulations of lateral and dorsal astrocytes, as well 
as ependymal cells. The neural cells of the developing spinal cord are very heterogeneous. 
Indeed, astrocytes constitute one of the most abundant cell populations in the developing 
spinal cord and are functionally heterogeneous derived from various progenitors (Tsai et 
al., 2012). The knowledge of their origins is still very limited. Previous studies showed that 
progenitors from the ventricular zone differentiate into different subtypes of astrocytes and 
are in general distributed radially, in accordance to the dorsal-ventral position of their 
progenitors (Hochstim et al., 2008; Tsai et al., 2012). Our data consistently showed that a 
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subset of EGFP+ astrocytes migrates to the lateral white matter horizontally with Reelin, 
Sox9, and GFAP expression, in line with a subpopulation of the astrocytes reported by 
Hochstim et al. (Hochstim et al., 2008). However, our data complimentarily showed that a 
subset of EGFP+ astrocytes migrates to the dorsal white matter, as a subpopulation of 
PAX3+ astrocytes in the dorsal spinal cord (Tsai et al., 2012). We suggest that FoxJ1 is 
expressed in progenitors of both neuronal and astrocytes, and that FoxJ1 can be further 
used as a new marker to study neural cells during spinal cord development. 
To further understand the role of FoxJ1 in the developing and adult spinal cord, we used 
FoxJ1-CreERT2-YFP and FoxJ1-CreERT2-KI-TdTomato mouse lines. We observed that 
after the loss of one or two alleles of the foxj1 gene, less FoxJ1 promoter-active cells are 
capable of proliferating with a five-fold decrease, and they leave the progenitor stage earlier 
by showing less Sox9 and Vimentin expression but become more neurogenic by expressing 
more interneuron marker Pax2. However, these cells are disrupted for maturation as they 
are not able to express mature neuron marker NeuN. As previous studies showed that FoxJ1 
is involved in the migration and differentiation of progenitor cells towards the olfactory 
bulbs (Jacquet et al., 2011), our data further expand the understanding of FoxJ1 from brain 
to the CNS development. Our study suggests that FoxJ1 is involved in the proliferation and 
is required for normal cell fate specification of progenitors during spinal cord development. 
Moreover, we further discovered that FoxJ1 also plays a role in the maintenance of stem 
cell potential in adulthood besides its function during development. After embryonic 
development, the stem cell potential is entirely confined to ependymal cells since P10 (Li 
et al., 2016). Even though we were not able to acquire FoxJ1-/- mice postnatally due to the 
lethal effects of losing FoxJ1 (Muthusamy et al., 2014), FoxJ1+/- mice showed that the self-
renewal potential of ependymal cells was largely impaired at both P10 and adulthood. 
Indeed, in both FoxJ1-CreERT2-YFP and FoxJ1-CreERT2-KI-TdTomato mouse lines, the 
central canals were occupied by FoxJ1+ ependymal cells since P10, but only 60% of the 
neurospheres derived from the spinal cord were recombined in FoxJ1+/- mice, compared to 
90% from the FoxJ1-CreERT2-YFP mice (FoxJ1+/+), indicating that a large population of 
ependymal cells does not have stem cell potential after the loss of one copy of FoxJ1. From 
the second generation of neurosphere culture, we observed that all the neurospheres from 
both mouse lines were recombined, suggesting that the only stem cell source is still 
ependymal cells, and the loss of FoxJ1 impairs the self-renewal potential of ependymal 
cells but does not promote another stem cell niche in the spinal cord. Moreover, 
differentiation assay showed that the FoxJ1+/- neurospheres are more neurogenic but failed 
to generate oligodendrocytes, which is in line with our in vivo data during development that 
FoxJ1-/- progenitors are more differentiated and more neurogenic.  
Interestingly, our study timely gives more insights into a debate about the contribution of 
ependymal cells after SCI. Ependymal cells have been shown to be the only cell type with 
multipotency after SCI (Barnabe-Heider et al., 2010; Meletis et al., 2008), and contribute 
to the reinforcing of the injured spinal cord by restricting tissue damage and neural loss 
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(Sabelstrom et al., 2013). However, a recent study contradictorily showed that by using 
FoxJ1-CreERT2-KI-TdTomato mice, the contribution of ependymal cells to scar formation 
after SCI is very limited (Ren et al., 2017). To test whether the injury could rescue the 
decreased self-renewal capacity of FoxJ1+/- ependymal cells, we performed the same SCI 
in both FoxJ1-CreERT2-YFP (FoxJ1+/+) and FoxJ1-CreERT2-KI-TdTomato (FoxJ1+/-) 
mice. We found that the effects of the FoxJ1 deletion on the stem cell potential of 
ependymal cells are permanent. Indeed, the FoxJ1+/- ependymal cells did not migrate to the 
injury site as much as the FoxJ1+/+ ones, and the FoxJ1+/- ependymal cells showed similar 
phenotype as those before SCI, regarding decreased self-renewal potential and failure to 
generate oligodendrocytes. Therefore, our study suggests that FoxJ1 is required for the 
maintenance of normal stem cell potential of ependymal cells postnatally and after SCI. 
Further usage of FoxJ1-CreERT2-KI-TdTomato mice for lineage tracing might be more 
limited than what the authors claimed as one copy of FoxJ1 is knocked out (Muthusamy et 
al., 2014). Therefore, the FoxJ1-CreERT2-KI-TdTomato mice need more characterization 
before used for more analysis.  
4.2 THE REGENERATIVE POTENTIAL OF EPENDYMAL CELLS FOR SCI 
OVER TIME 
Ependymal cells have been discovered as the only stem cells in the spinal cord and 
proposed as a target for non-invasive cell therapy for SCI (Barnabe-Heider et al., 2010; 
Meletis et al., 2008). However, when the ependymal cells have developed stem cell 
potential and how their potential can change over time were not clear. As the majority of 
SCI affected people are 10-40 years old at the time of injury (Siddiqui et al., 2015), and the 
recovery potential of the spinal cord after injury declines during aging (DeVivo et al., 1990; 
Furlan et al., 2010; Wyndaele and Wyndaele, 2006), it is crucial to understand how the 
potential of endogenous stem cell changes over time to develop translational therapies for 
patients of different ages. 
Although it was previously suggested that ependymal cells could be targeted for stem cell 
therapy without invasive surgery, it was not known that when and how the ependymal cells 
become stem cells. In Paper II, using non-inducible FoxJ1::EGFP mice where EGFP is 
expressed under the active FoxJ1 promoter, we found that ependymal cells are first born at 
E15 in mice, and the spinal cord stem cell potential is entirely confined to ependymal cells 
from early postnatal stage P10, suggesting that treatments modulating ependymal cells for 
SCI can be applied to patients at almost all ages. Consistent with other studies that the 
spinal cord become less regenerative with aging (DeVivo et al., 1990; Furlan et al., 2010; 
Wyndaele and Wyndaele, 2006), we found that the ability of ependymal cells to self-renew 
declines from juvenile stage to adulthood and this capacity is also less re-activated after 
SCI. Moreover, ependymal cell-derived neurospheres differentiate into significantly fewer 
oligodendrocytes in adulthood compared to in juvenile stage, but we found no difference 
in neuronal differentiation when comparing different ages. It was shown that during aging, 
neural stem cells lose their stem cell potential after traumatic brain injury (Conover and 
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Shook, 2011; Sun et al., 2005). Both of our data and previous publications suggest that it 
would be more beneficial to modulate ependymal cell differentiation after SCI into 
oligodendrocytic lineage instead of neurons, since ependymal cells do not give rise to 
neurons in vivo at different ages and their neuronal differentiation potential is not age-
dependent in vitro after SCI (Barnabe-Heider et al., 2010; Li et al., 2016).  
Adult ependymal cells are capable of differentiating into astrocytes and oligodendrocytes 
in vivo after SCI, and the differentiated progeny migrate to the lesion area (Barnabe-Heider 
et al., 2010; Meletis et al., 2008). However, although juvenile ependymal cells have greater 
self-renewal potential, we found that there are no migration of the ependymal lineage cells 
to the lesion site after dorsal funiculus transection (DFT), a mild SCI model. On the 
contrary, after more severe SCI, dorsal hemisection (DH), juvenile ependymal cells and 
their progeny migrate to the lesion site, suggesting that the juvenile spinal cord environment 
after injury is different from that of adults. Despite the higher intrinsic stem cell potential, 
juvenile ependymal cells are not recruited if the injury can be sealed by other cell types. 
It has been well studied that after SCI, several endogenous cell types are required to 
contribute to the wound healing and scar formation in a distinct manner, including 
ependymal cells, astrocytes and stromal-derived pericytes (Anderson et al., 2016; Goritz et 
al., 2011; Sabelstrom et al., 2013). Ependymal cell-derived astrocytes are located in the 
core while resident astrocytes are at the border of the lesion site after SCI (Barnabe-Heider 
and Frisen, 2008; Burda and Sofroniew, 2014). We observed that both the lesion core 
(where reactive astrocytes do not infiltrate) and the surrounding area with astrogliosis 
(where the reactive astrocytes accumulate) in juvenile mice after DFT are smaller than 
those in adults, indicating that the juvenile spinal cord can seal the lesion site more 
efficiently than adult after a mild injury. After DH, these areas show no significant 
difference between juvenile and adults, but juvenile ependymal cells are activated and their 
progeny is capable to migrate after this more severe injury, further suggesting that the 
recruitment of ependymal cells to the injury site is dependent on the self-healing efficiency 
of the spinal cord. 
Indeed, our data showed that there is increased activation and infiltration of microglia and 
blood-derived macrophages in adult mice compared to in juvenile mice after mild injury. 
The activation and recruitment of these immune cells reached the same level when 
comparing adult with a mild lesion to the juvenile with a severe lesion. Pericytes are the 
primary cell type forming the fibrotic cap filling the lesion site after SCI (Dias et al., 2018; 
Goritz et al., 2011). Consistent with our suggestion that the juvenile spinal cord is more 
regenerative, we observed that the infiltration by pericytes in injured juvenile mice is 
significantly less than the one in adults after the same type of SCI. This observation is 
probably due to the higher repair mechanism of astrocytes at the younger age and the age-
dependent transcriptomic changes regarding inflammation or metabolism (Noor et al., 
2011; Saunders et al., 2014). 
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To further understand whether ependymal cells are needed only when the regeneration is 
largely insufficient, due to aging or a larger injury, we used FoxJ1-CreERT2-Rasless-YFP 
mice to block the cell cycle of ependymal cells. Consistent with a previous study we found 
that lacking proliferative ependymal cells after SCI in adulthood leads to the formation of 
an enlarged cyst at the lesion site (Sabelstrom et al., 2013). However, using this transgenic 
model in juvenile mice, we found no cysts or enlarged lesion sites after DH injury, and the 
astrogliosis and stromal infiltration areas at the injury site of juvenile mice are significantly 
smaller than in adults. These data confirm that ependymal cells serve as a backup 
participant for regeneration after SCI and juvenile spinal cords have a more pronounced 
potential for self-repair. Notably, in line with our findings, a recent clinical study reveals 
that younger patients with SCI have better overall health and functional recovery as well as 
reduced pain (Ma et al., 2016). It is suggested that modulating endogenous cell types would 
allow the development of non-invasive therapeutic possibilities to avoid the complications 
associated with cell transplantation (Barnabe-Heider and Frisen, 2008; Coutts and 
Keirstead, 2008). Therefore, our understanding about age- and lesion size-dependent self-
repair of spinal cords provides more clues for future individual therapy development and 
suggests that adequately tuning the response of ependymal cells and other glial cells should 
be explored to promote spinal cord repair after SCI. 
4.3 THE TRANSPLANTATION OF BOECS PROMOTES THE REGENERATIVE 
POTENTIAL OF ENDOGENOUS PROGENITORS AFTER SCI  
Even though the recruitment of endogenous ependymal cells presents a promising potential 
for the cure of SCI, there need more investigations of its mechanisms before clinical 
application. On the other hand, cell transplantations are more studied (Assinck et al., 2017; 
Kabu et al., 2015; Vismara et al., 2017; Yang et al., 2015). Stem cell transplantations, 
including ESCs, iPSCs, NSCs have shown the potential to compensate for cell loss but are 
still under challenge due to difficulties to control of their proliferation and cell fates 
(Assinck et al., 2017). OECs, a glial cell type, however, have shown to be beneficial for 
SCI recovery in both animal studies and clinical trials with human patients (Mayeur et al., 
2013; Tabakow et al., 2014). However, studies focusing on OEC transplantation are usually 
limited to axonal regrowth and their enrichment of microenvironment (Gomez et al., 2018). 
Since OEC transplantation achieve such significant functional recovery in clinical trials 
(Tabakow et al., 2013; Tabakow et al., 2014; Wang et al., 2016a), we hypothesized that the 
transplanted OECs also have effects on endogenous progenitors and stem cells. In paper 
III, we used different transgenic mice and single nucleus sequencing techniques to fate map 
ependymal stem cells and other endogenous progenitors, to further understand the effects 
of bOEC transplantation on these progenitors.  
To investigate the effects of bOEC transplantation on ependymal cells after SCI, we used 
FoxJ1-CreERT2-YFP mice for proliferation, differentiation and neurosphere assays. We 
found that after SCI, ependymal cells showed higher reactivity in terms of self-renew and 
neural differentiation compared to non-injured group in vitro, similar to what was seen in 
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previous studies (Barnabe-Heider et al., 2010; Cusimano et al., 2018; Li et al., 2016; 
Meletis et al., 2008). Indeed, our in vitro neurosphere assay also showed that significantly 
larger number of neurospheres were derived from the same number of ependymal cells 
after bOEC transplantation, suggesting that the transplantation of bOECs increases the 
proliferation of ependymal cells and their self-renewal capacity. Similarly, with bOEC 
transplantation, we found that the proliferation of ependymal cells were even more highly 
activated by showing a significantly higher percentage of EdU+YFP+ cells in vivo.  
To study the effects of bOEC transplantation on the progeny of ependymal cells, we 
analyzed animals two weeks and three months after surgery. We found that bOEC 
transplantation did not change the oligodendrocytic differentiation potential of ependymal 
cells, while the transplantation enhanced astrocytic differentiation of ependymal cells, with 
a higher percentage of GFAP+YFP+ cells. Moreover, the newly derived astrocytes from 
ependymal cells showed less Neurocan expression in vivo, suggesting that bOEC 
transplantation promotes astrogliogenesis but reduces axonal inhibition. Interestingly, our 
previous study showed that ependymal cell-derived neurospheres can differentiate into 
more oligodendrocytes and neurons in vitro after SCI (Li et al., 2016), our differentiation 
assay here showed that the SCI-induced activation of oligodendrocytic differentiation is 
highly associated with SCI, regardless of bOEC transplantation; whereas the neuronal 
differentiation potential of neurospheres can be increased with bOEC transplantation, 
regardless of SCI.  
To further investigate why the differentiation potential of ependymal cells are changed 
upon bOEC transplantation, we further performed qPCR to analyze the micro-environment. 
Our qPCR data showed that after bOEC transplantation, there was an increase of the mRNA 
level of a few axonal growth permissive molecules, whereas the mRNA level of mostly 
axonal growth inhibitory molecules decreased, suggesting that bOEC transplantation 
enriched the micro-environment by inhibiting the inhibitors of axonal growth. Moreover, 
neuronal survival was significantly increased with bOEC transplantation, and this effect 
could be seen from 2 weeks to 3 months after transplantation. Therefore, our data suggested 
that bOEC transplantation results in the more enriched microenvironment, regarding axonal 
growth and neuronal survival. As ependymal cells are also crucial to reinforce the spinal 
cord after SCI by serving as a source of neurotrophic support for neuronal survival and 
wound healing (Sabelstrom et al., 2013), we further investigated the effects of bOEC 
transplantation per se on the injured spinal cord by using FoxJ1-CreERT2-Rasless mice to 
block the cell cycle of ependymal cells. We found that with bOECs, the wound healing 
process was more efficient in FoxJ1-CreERT2-Rasless mice, suggesting that bOEC 
transplantation per se benefits glial scar formation. Even though neuronal survival 
significantly decreased without the proliferation of ependymal cells, comparing FoxJ1-
CreERT2-Rasless mice to FoxJ1-CreERT2-YFP mice, the number of survived neurons 
remained at the same level with bOEC transplantation from 2 weeks to 3 months after SCI, 
indicating that bOEC transplantation protects neurons from apoptosis to a certain degree.   
Moreover, qPCR data showed that there were no significant differences among the mRNA 
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level of axonal growth or inhibition molecules after SCI with or without transplantation in 
FoxJ1-CreERT2-Rasless mice without proliferating ependymal cells. Therefore, these data 
suggest that the enrichment of microenvironment by bOEC transplantation is beneficial, 
but that ependymal cells are needed for the better effect.    
It has been widely accepted that the regeneration of adult spinal cord is very limited and 
there is no adult neurogenesis in the spinal cord under physiology condition or after SCI 
(Barnabe-Heider et al., 2010; Sabelstrom et al., 2014; Sabelstrom et al., 2013). However, 
we unexpectedly discovered a few EdU+DCX+ cells two weeks after SCI with bOEC 
transplantation, and mature neurons co-labeled with EdU and NeuN were found three 
months after injury, suggesting that bOECs promotes adult neurogenesis after SCI. 
Interestingly, when we transplanted bOECs to FoxJ1-CreERT2-Rasless mice where the cell 
cycle of ependymal cells was blocked, we did not find any newborn neurons. With co-
transplantation of bOECs and ependymal cell-derived neurospheres, we did not find rescue 
effects of neurogenesis, suggesting that endogenous ependymal cells are necessary for the 
neurogenesis process promoted by bOEC transplantation. A recent study showed that using 
single nucleus sequencing (Div-Seq), rare neurogenesis was found in the adult spinal cord, 
and suggesting that the undiscovered spinal cord neurogenesis could be due to technical 
limitations in the past (Habib et al., 2016). Indeed, using immunohistochemistry, we failed 
to find any newborn neurons in both uninjured and injured spinal cords without bOEC 
transplantation. Therefore, our results suggest that together with ependymal cells, bOEC 
transplantation promotes adult neurogenesis to a detectable level by immunostaining, but 
more precise quantification needs to be performed in the future. 
To further investigate the origin of newborn neurons and the progeny of endogenous 
progenitors upon bOEC transplantation, we used numerous transgenic mice: FoxJ1-
CreERT2-YFP, PDGFRα-CreERT2-GFP, Connexin 30-CreERT2-GFP, hGFAP-CreERT2-
YFP and GLAST-CreERT2-Tomato to fate map ependymal cells, OPCs, and subtypes of 
astrocytes (Ganat et al., 2006; Meletis et al., 2008; Mori et al., 2006; Rivers et al., 2008; 
Slezak et al., 2007). We found that the GLAST and Connexin 30 lineage cells give rise to 
DCX+EdU+Reporter+ or DCX+Reporter+ cells after two weeks of bOEC transplantation 
in the injured spinal cord, suggesting that some subtypes of astrocytes might be the origin 
of progenitors that give rise to newborn neurons. Long-term lineage tracing for these cells 
is ongoing, and we expect to see NeuN+EdU+Reporter+ cells from Connexin or GLAST 
lineages. 
Furthermore, a recent study showed that a new technique, DroNc-Seq can perform 
sensitive, efficient and unbiased classification of cell types for charting systematic cell 
atlases (Habib et al., 2017). We used DroNc-Seq to analyze the single cell profile after SCI 
with and without bOEC transplantation. We found 16 subpopulations of neural cells with 
different gene expression profile, some of which are unreported cell types. Moreover, we 
also discovered significant alteration of gene expression at both cluster and single nucleus 
level comparing SCI animals with and without bOEC transplantation, indicating that bOEC 
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transplantation indeed has effects on the endogenous stem and progenitor cells. We are 
currently completing the analysis, and expect to provide an atlas of the alteration in all the 
endogenous neural cells after bOEC transplantation in the SCI animals.   
Altogether, our study provides integrative insight into the effects of bOEC transplantation 
on endogenous progenitors. These data give clinical relevance and the mechanistic 
understanding, revealing that together with ependymal cells, bOEC transplantation 
promotes gliogenesis and neurogenesis, inhibits axonal growth inhibitors, and promotes 
neuronal survival after spinal cord injury.  
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5 CONCLUSIONS 
The adult spinal cord has limited regenerative potential, resulting in poor recovery after 
spinal cord injury. Moreover, the development of the spinal cord is still not well studied, 
and the link between the development of spinal cord progenitors and adult spinal cord 
regeneration has been largely overlooked. Therefore, this thesis sheds some light on the 
regulation of spinal cord progenitor development, the different regeneration capacity after 
SCI during juvenile and adulthood, and the mechanisms behind clinical cell therapies for 
SCI.  
In Paper I, we discovered that FoxJ1, a classical transcription factor involved in 
ciliogenesis, has broader functions in the regulation of both spinal cord development and 
the stem cell potential after SCI. We found that during embryonic development, FoxJ1 is 
transiently expressed in neuronal and glial progenitors, which will further give rise to 
subsets of interneurons and two subsets of astrocytes and all ependymal cells. FoxJ1 is 
required for the maintenance of stemness of the progenitors during development and the 
stem cell potential during adulthood. After SCI, FoxJ1 is required for the normal stem cell 
potential, proliferation and migration of ependymal cells for regeneration.     
In Paper II, we observed that the stem cell potential is confined to ependymal cells since 
P10 in mice, and the potential of self-renewal and oligodendrocytic differentiation 
decreases over time. Juvenile ependymal cells are more highly activated after SCI than 
adult ones in vitro, but their contribution to the glial scar formation in vivo is lesion size- 
and age-dependent. The resident astrocytes and stromal derived pericytes show higher 
regenerative potential at the juvenile stage, while ependymal cells serve as a backup 
regeneration candidate after SCI.    
In Paper III, we found that after SCI, bOEC transplantation increases the proliferation and 
self-renewal potential of ependymal cells both in vivo and in vitro. The transplantation of 
bOECs promotes higher astrocytic differentiation of ependymal cells but reduces the 
axonal growth inhibitors after SCI. The microenvironment of the injured spinal cord is 
enriched after bOEC transplantation regarding less axonal growth inhibitor, a higher level 
of neurotrophic factors and better neuronal survival. Unexpectedly, we found newly born 
neurons after SCI with bOEC transplantation, highly probably from endogenous astrocytes, 
challenging the current central stream theory that there is no neurogenesis after SCI. We 
also provided an integrative map of the cell profile of endogenous progenitors with DroNc-
Seq technique, revealing that the alteration of gene expression after bOEC transplantation 
in SCI animals.    
Altogether, this thesis gives new insights into the development and potential of spinal cord 
progenitors and stem cells and provides inspirations for future SCI therapeutic possibilities. 
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6 FUTURE PERSPECTIVES  
6.1 FOXJ1 REGULATES SPINAL CORD DEVELOPMENT AND STEM CELL 
POTENTIAL AFTER SCI 
Foxj1 is associated with the production and function of motile cilia at many sites (Blatt et 
al., 1999; Brody et al., 2000; Chen et al., 1998; Lim et al., 1997). Together with recent 
studies, our data also showed that FoxJ1 is also required for the CNS development and stem 
cell potential after SCI (Jacquet et al., 2011; Jacquet et al., 2009; Li et al., 2018; Shimada 
et al., 2017). However, the mechanistic study is needed to understand further how FoxJ1 
regulates the maintenance of stemness of progenitors and stem cells. Some studies have 
shown that FoxJ1 is a target of Shh, Mcidas and GemC1 during CNS development (Cruz 
et al., 2010; Kyrousi et al., 2015; Kyrousi et al., 2016; Yu et al., 2008). A recent study 
showed that suppressing Notch leads to the upregulation of FoxJ1, which further promotes 
ependymal niche development (McClenahan et al., 2016). These studies, however, only 
provide insights how FoxJ1 is regulated as a downstream target. Therefore, further study 
on how FoxJ1 regulates other molecules and how these regulation effects on neural 
stem/progenitor cells during development and after SCI are needed. 
We hypothesize that FoxJ1 plays a dual role in the spinal cord, as it maintains the stem cell 
potential during development and after SCI, but seems to inhibit the dedifferentiation of 
ependymal cells in adulthood. Indeed, even though the deletion of FoxJ1 leads to lower 
proliferation and pre-differentiation of progenitors during spinal cord development, as well 
as results in lower self-renewal potential of ependymal cells in adulthood, it is interesting 
to note that the lack of one copy of FoxJ1 postnatally results in high neuronal differentiation 
in vitro (Li et al., 2018/Paper I). We did not find any newborn neurons in heterozygous 
FoxJ1-Knockout mice after SCI (unpublished data), but whether a complete deletion of 
FoxJ1 after SCI in the adult can induce neurogenesis is not known. By using FoxJ1::EGFP 
mice, we found that ependymal cells lose FoxJ1 expression when dedifferentiating and 
migrating to the lesion after SCI in vivo, and that ependymal cells lose FoxJ1 expression 
when generating neurospheres and differentiate into astrocytes and oligodendrocytes in 
vitro (unpublished data). These data suggest that FoxJ1 might be an inhibitor for 
spontaneous dedifferentiation of ependymal cells. Therefore, whether FoxJ1 has dual 
functions during development and after SCI, and how these phenotypes are regulated will 
be an exciting topic in Developmental Biology and Regenerative Medicine.  
To be able to investigate the questions above in the future, a more precise genetically 
engineered mouse model is needed. Indeed, the models to study FoxJ1 and ependymal cells 
are under controversy. The transgenic mouse models for lineage tracing in Paper I are 
mainly based on a human FoxJ1 promoter, which arouses the doubts and critics that the 
transgene may influence the effect of endogenous FoxJ1 expression (Ren et al., 2017). Even 
though in previous studies and Paper I, we have characterized the expression of FoxJ1 and 
the phenotype of ependymal cells are highly similar to WT mice during development, 
adulthood and after SCI, it will be less concerned by peers if a mouse model with 
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endogenous mouse FoxJ1 promoter can be developed (Barnabe-Heider et al., 2010; Li et 
al., 2018; Meletis et al., 2008). On the other hand, a knock-in mouse model with 
endogenous FoxJ1 promoter was recently developed, and researchers claimed that it is 
feasible as a lineage tracing tool to study FoxJ1 expressing cells (Muthusamy et al., 2014). 
However, despite the advantage of its endogenous promoter, a CreER locus was inserted 
into an exon of the FoxJ1 gene, resulting in the deletion of the FoxJ1 expression 
(Muthusamy et al., 2014). The phenotype of ependymal cells and other neural progenitors 
are thus influenced (Li et al., 2018/ Paper I). Moreover, as the CreER is knocked in and 
disrupt the endogenous FoxJ1 gene, the animals with lineage tracing possibility are 
FoxJ1+/- or FoxJ1-/- since E1. Therefore, a mouse model with an endogenous FoxJ1 
promoter and flox loci for conditional FoxJ1 knockout will be beneficial to study FoxJ1. 
6.2 JUVENILE AND ADULT EPENDYMAL CELLS HAVE DIFFERENT 
REGENERATIVE MECHANISMS 
Previous studies provided that ependymal cells play a crucial role in glial scar formation 
and can be targeted as a non-invasive therapy for SCI (Barnabe-Heider et al., 2010; 
Sabelstrom et al., 2013). Our study expands the understanding of ependymal cells that 
juvenile ependymal cells have higher stem cell potential than adult ones but serve as a 
backup rescue player after SCI. We also found that juvenile spinal cord is more regenerative 
than adult (Li et al., 2016/Paper II). We performed dorsal funiculus lesion and dorsal 
hemisection lesion to the animals, both of which give clear observation possibilities to 
study different cell types. Even though these two models are not the perfect model to mimic 
clinical cases, compared to a contusion injury model, previous studies have provided other 
SCI models, such as lateral spinal cord lesion and crush injury, and show similar response 
of ependymal cells in dorsal injury models (Barnabe-Heider et al., 2010; Lacroix et al., 
2014; Meletis et al., 2008; North et al., 2015). However, to be further study the application 
possibility of modulating ependymal cells, further characterization by using more clinically 
relevant SCI models is needed. Moreover, even though neurosphere-forming cells were 
found in the adult human spinal cord, there is no direct proof that whether these stem cells 
are originated from ependymal cells, and whether other cell types display stem cell 
potential after SCI in human (Dromard et al., 2008). To be able to move forward the 
ependymal cell-based therapy, more investigation on human tissue is needed.   
The other perspective regarding modulating ependymal cells after SCI is whether we can 
rejuvenate the aged ependymal cells and progenitors for better regeneration. The 
mechanism behind the difference of regenerative potential comparing juvenile and adult 
stem cells and progenitors is not in-depth studied yet. However, several signaling pathways 
and molecules have been found to be associated with stem cell aging throughout different 
organs, such as FGF, mTOR, Wnt and TGF-β (Brack et al., 2007; Chakkalakal et al., 2012; 
Chen et al., 2009; Yousef et al., 2015). In the central nervous system, the system melieu 
has been shown to be important for aging and rejuvenating neural stem cells (Ruckh et al., 
2012; Villeda et al., 2011). Furthermore, a recent study showed that microRNA derived 
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from stem/progenitor cells is capable to reserve aging in the brain (Zhang et al., 2017). 
Therefore, further studies on these molecules and microenvironment for ependymal cells 
after SCI will be beneficial for further modulating these stem cells. 
6.3 BOEC TRANSPLANTATION EFFECTS ON THE REGENERATIVE 
POTENTIAL OF ENDOGENOUS STEM/PROGENITOR CELLS  
Transplantation of OECs to injured spinal cord has been extensively used in SCI study, 
both in animals and human and achieve functional recovery, by modulating the glial scar 
and benefit axonal regeneration (Gomez et al., 2018). Our study provides insights into the 
transplantation effects from another perspective, showing that bOEC transplantation 
promotes the regenerative potential of endogenous ependymal cells, astrocytes, and stromal 
derived pericytes. While the manuscript is still incomplete, we will further address the 
question how the fate of endogenous stem cells and progenitors are affected after bOEC 
transplantation, by using different lineage tracing models to fate map ependymal cells, 
different subtypes of astrocytes and OPCs. Together with a newly developed single nucleus 
sequencing technique, DroNc-seq, the lineage tracing results and the RNA profile of single 
cells will provide an integrative map of the cell fates after bOEC transplantation treatment 
on SCI mice.    
The adult spinal cord has been long seen as non-neurogenic, but we found that bOEC 
transplantation can unexpectedly promote adult neurogenesis after SCI, which was 
traditionally seen as impossible. To be able to understand further the adult neurogenesis 
process promoted by bOEC transplantation, we will perform another single nucleus 
sequencing, Div-Seq to study the subtype of newborn neurons. Taking advantage of the 
lineage tracing mouse lines, we will further trace the origin of the newborn neurons. 
Besides, we will perform electrophysiology on these newborn neurons for functional 
characterization.   
Clinically, the patients who received autologous OEC transplantation obtained functional 
recovery, but the sacrifice of half of the olfactory bulb still causes concern of ethical issues 
and the risk of impairing smelling sensitivity (Tabakow et al., 2013; Tabakow et al., 2014) 
(Cell transplantation 2013). Analyzing and identifying the molecules secreted by bOECs 
will probably replace the whole bulb isolation with industrial synthesized factors, and 
decrease the complication of this therapy and increase the neurogenesis efficiency. 
Altogether, this thesis gives new insights into the development and potential of spinal cord 
progenitors and stem cells, and provides inspirations for future SCI therapies. 
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